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Cellular differentiation is a process regulated by environmental, intracellular and 
intercellular factors. Myogenesis is a differentiation program in mammalian myotome 
cells in which Pax3 activates myogenic transcription factors to convert myotome cells to 
committed myoblasts. Myoblasts differentiate to become fully differentiated, multi-
nucleated myotubes (Tajbakhsh et al., 1997). C2C12 cells are a model system for 
myogenesis. We noted that Bcl2-associated transcription factor (Btf) is upregulated 
during myogenesis. We observed that C2C12 nuclei reorganize during myogenesis. We 
observed that myoblast nuclei have approximately 5-10 small nucleoli, while nuclei in 
myotubes have fewer and larger nucleoli. Nucleolar reorganization occurs independently 
of multinucleation. Also, the reorganization is not a result of serum withdrawal, as other 
cell lines fail to show reorganization when grown in low serum conditions. 
Immunofluorescent data indicates nuclear speckles reorganize during myogenesis. Our 
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Chapter One: Background and Significance 
1.1 Nuclear Domains 
The cell nucleus orchestrates numerous processes including DNA replication, DNA 
repair and recombination, ribosomal subunit assembly, nucleocytoplasmic and 
ribonucleoprotein trafficking, and pre-mRNA processing (Lamond and Earnshaw, 1998). 
These functions are often focused around distinct non-membrane bound organelles that 
include paraspeckles, nucleoli, perinucleolar compartments, Cajal bodies, Gems, 
promyelocytic leukemia (PML) bodies, and nuclear speckles (Spector, D.L., 2001; 
Lamond and Spector, 2003). The structural integrity and/or biogenesis of these 
organelles can often be attributed to sequence motifs found within the proteins that 
localize to these organelles (Taddei et al., 2004). These motifs mediate protein-protein 
and protein-nucleic acid interactions that result in self-assembly of these organelles 
(Taddei et al., 2004). For example, immunofluorescence studies using monoclonal 
antibodies localized the protein p120 to the nucleolus. These studies used site-directed 
mutagenesis to identify an arginine-rich domain that overlapped with the protein‟s 
nucleolar localization signal that was similar to that of other rRNA-binding proteins 
(Freeman et al., 1988; Gustafson et al., 1998). This data suggested that the nucleolus 
was capable of self-assembly and did not require an underlying scaffold structure 
(Gustafson et al., 1998). Nuclear speckles are also enriched with proteins whose 
sequence motifs are responsible for targeting them to nuclear speckles. Caceres and 
colleagues transiently overexpressed several cDNAs for epitope-tagged SR proteins 
coding for either the wild type protein or a deletion mutant construct and then studied the 
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cellular distribution of the tagged proteins (Caceres et al., 1997). This study revealed an 
arginine-serine rich (RS) domain within several SR pre-mRNA splicing factors that was 
necessary for targeting these proteins to nuclear speckles (Caceres et al., 1997). It is 
possible that additional mechanisms also support the organization of nuclear bodies. 
siRNA depletion of nuclear speckle protein Son showed a change in nuclear speckle 
morphology from a solid sphere to a “donut” shaped morphology suggesting Son may 
lend structural integrity to nuclear speckles and possibly serve as a protein scaffold for 
nuclear speckles (Sharma et al., 2010). In addition, a growing number of noncoding 
RNAs are involved in organization of nuclear bodies or their residential proteins. MALAT-
1 is needed for proper distribution of splicing factors in nuclear speckles (Tripathy et al., 
2010). Men ε and Men β are required for the integrity of nuclear paraspeckles (Sunwoo 
et al., 2008). 
 
1.2 The Nucleolus 
 Organelles and other structures within interphase nuclei exhibit a non-random 
spatial organization in which each structure occupies a distinct and characteristic region 
or domain. The nucleolus is the most dominant function-based compartment within the 
nucleus. The nucleolus is the site of RNA polyermase I-mediated rDNA transcription and 
ribosomal subunit assembly (Taddei et al., 2004). The nucleolus is composed of three 
main sections, the innermost fibrillar center (FC), the dense fibrillar component (DFC), 
and the granular component (GC) (Taddei et al., 2004). Both the GC and DFC are 
embedded in the GC (Sirri et al., 2008). The FC has active and inactive rDNA genes and 
the DFC is where processing and assembly of rRNA takes place (Taddei et al., 2004). 
Finally, the later stages of ribosomal maturation and assembly take place in the GC 
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(Taddei et al., 2004). Nucleoli localize to tandem repeats of rDNA known as nucleolar 
organizing regions (NORs) (Taddei et al., 2004). Localization studies of NORs using 
immunofluorescence microscopy have showed that NORs associate with the nuclear 
envelope (Trumtel et al., 2000). This localization has been shown to be RNA polymerase 
I dependent because when rDNA is transcribed with RNA polymerase II the localization 
of nucleoli shifts away from the nuclear envelope (Trumtel et al., 2000). This model was 
tested by disrupting the formation of the RNA polymerase I complex and then using 
immunofluorescence to study localization of nucleolar protein ssb1. Localization of 
ssb1had shifted away from the periphery of the nuclear envelope to internal regions of 
the nucleus (Oakes, 1998).  
The nucleolus forms around tandem repeats of rDNA referred to as nucleolar 
organizing regions (NOR‟s) (Schardin et al., 1985; Eils et al., 1996). The trans-
association of rDNA and NORs begins in an asynchronous manner shortly after 
telophase of mitosis (Savino et al., 2008). Using cells stably transfected with green 
fluorescent protein (GFP) tagged fibrillarin and GFP-tagged Nop52, localization of 
nucleolar proteins was tracked using live microscopy (Savino et al., 2008). Results of 
this study revealed that in early telophase, fibrillarin was concentrated in both 
prenucleolar bodies (PNBs) and NORs; whereas, PNBs enriched with Nop52 did not 
appear until later (Savino et al., 2008). Furthermore, analysis of PNBs revealed that 
nucleolar proteins are most likely progressively delivered to nucleoli in the form of large 
complexes based on their appearance through electron microscopy (Savino et al., 
2008). Using a combination of immunofluorescence, electron microscopy, and in situ 
hybridization to study localization of RNA polymerase I upstream binding factor (UBF), 
nucleolin, fibrillarin, and pre-rRNAs throughout mitosis and the beginning of interphase 
revealed the nucleolar assembly occurred independently of rDNA transcription and prior 
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to chromosome decondensation (Dousset et al., 2000). Other non-random aspects of 
nuclear organization have been seen with Cajal bodies.  Cajal bodies are localized 
predominantly in the nucleoplasm at the periphery of nucleoli and to a lesser extent 
within nucleoli (Malatesta et al, 1994). Interestingly, Cajal bodies show dynamic 
organization within cell nuclei. Time-lapse confocal microscopy revealed that Cajal 
bodies are mobile structures that may actually pass through nucleoli (Boudonck et al., 
1999). Nuclear body dynamics has also been observed for PML bodies, a subclass of 
which shows metabolic-energy-dependent movement through the nucleoplasm 
(Muratani et al., 2001). 
 
1.3 Nuclear Speckles 
Nuclear speckles were first reported by Hewson Swift in 1959 and termed 
interchromatic particles based on their appearance and localization as observed by 
electron microscopy (Swift, 1959). In 1961, the term “speckles” was introduced by J. 
Swanson Beck after he examined rat-liver sections which had been immunolabeled with 
the serum from patients suffering from autoimmune disorders (Beck, 1961). The 
connection between pre-mRNA splicing factors and speckles was first revealed when 
immunolabeling studies showed that nuclear speckles have small nuclear 
ribonucleoprotein (snRNP) splicing factors (Spector, et al., 1983). Nuclear speckles were 
later shown to be the equivalent of the interchromatin granule clusters (IGCs) (reviewed 
in Lamond and Spector, 2003.). IGCs vary in size and are irregularly shaped (Thiry, 
1995). Nuclear speckles are located exclusively in the nucleus, contain little to no DNA 
and are distinct from other splicing factor-containing structures in the nucleus such as 
perichromatin fibrils, Cajal bodies, interchromatin granule-associated zones, and 
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paraspeckles (Huang and Spector, 1997; Thiry, 1995; Fox et al., 2002). In situ 
hybridization studies show that highly active genes and transcripts are associated with 
the periphery of nuclear speckles and BrUTP labeling in permeabilized mammalian cells 
showed that transcription also occurs within nuclear speckles (Wei et al., 1999; Xing et 
al., 1995).  
Nuclear speckles contain pre-mRNA splicing factors including snRNPs and SR 
proteins (proteins with a region rich in arginine and serine residues) as observed by 
immunolabeling of these proteins (Fu, 1995). Additionally, proteomic analysis of nuclear 
speckles revealed that speckles contain the large subunit of RNA polymerase II (Saitoh 
et al., 2004). Studies revealing the dynamic behavior of nuclear speckles have shown a 
constant flux of splicing factors between nuclear speckles and the nucleoplasm, which 
suggested that nuclear speckles serve as storage sites for pre-mRNA processing 
machinery (Saitoh et al., 2004). Studies using live cell microscopy have documented the 
recruitment of splicing factors from nuclear speckles to sites of active transcription; 
furthermore, when pre-mRNA splicing is inhibited, speckles round up and become larger 
and more defined (Misteli, et al., 1997; O‟Keefe, R.T., et al., 1994). Misteli et al. (1996) 
reported that phosphorylation of the RS domain of SR proteins mediates splicing factor 
recruitment to active transcription sites. Furthermore, the presence of a variety of 
kinases and phosphotases within nuclear speckles supports this hypothesis (Mintz et al., 
1999). In addition to splicing factor phosphorylation, the carboxy terminus of the large 
subunit of RNA polyermase II is also phosphorylated and required for targeting splicing 
factors to sites of active transcription (Misteli and Spector, 1999). Removal of the 
carboxy-terminus from the large subunit of RNA polyermase II inhibits both splicing 
factor recruitment to the transcription site and pre-mRNA processing (Misteli and 
Spector, 1999).  
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1.4 Cell Cycle Dynamics of Nuclear Domain Organization  
When cells enter mitosis, nuclear domains completely disassemble, then assemble 
in newly formed daughter nuclei, presumably using the above-described self-assembly 
mechanisms. Although direct comparisons have not previously been made, it seems 
reasonable that a similar assembly process to what has been observed for nucleoli in 
post-mitotic daughter cells could be involved in nucleolar reorganization in response to 
other biological cues. For part of my project, I wished to study nuclear reorganization 
during muscle cell differentiation. This situation is likely similar to mitotic exit, since 
differentiating muscle cells leave a proliferative state and become programmed toward a 
less proliferative, specific cell type. In order to properly describe subtle changes in 
nuclear organization as well as to put conclusions about my observations into context 
with what is already known about nucleolar organization, it was important to consider 
nuclear organization and dynamics of not only interphase cells but also cells undergoing 
mitotic division. In other words, an understanding of post-mitotic nuclear organization 
may lend insight to nuclear reorganization observed during muscle cell differentiation. 
During mitosis, nucleoli disassemble and are no longer visible during prophase when 
rDNA transcription is repressed (Sirri et al., 2008). Immunolabeling of rRNA processing 
machinery with autoimmune sera collected from patients showed that at the beginning of 
prophase, rRNA processing components do not stay associated with rDNA at the NORs 
but become distributed over the surface of chromosomes (Hernandez-Verdunt et al., 
1993; Gautier et al., 1992). Kinetic studies of fluorescently tagged RNA polymerase I 
subunit RPA39 and nucleolar protein fibrillarin revealed that these components 
transiently dissociate from NORs during metaphase and return in anaphase (Leung et 
al., 2004). Live cell microscopy with green fluorescent protein (GFP) tagged nucleolar 
proteins fibrillarin and Nop52 revealed that components of the dense fibrillar center 
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(DFC) and granular component (GC) portions of the nucleolus relocate to the 
chromosome periphery and migrate with chromosomes during telophase (Savino et al., 
2001). These proteins then assemble at pre-nucleolar bodies (PNBs) located at the 
chromosome surface followed by progressive delivery of nucleolar proteins to NORs 
(Savino et al., 2001).  
Also as part of my project, I wanted to document changes in nuclear organization of 
nuclear bodies during muscle cell differentiation.  Dynamics of nuclear bodies other than 
nucleoli has been documented during mitosis. For example, immunofluorescence 
microscopy using an anti-p80 coilin antibody revealed that Cajal bodies change in size 
and number during mitosis (Andrade et al., 1993). Serum starvation studies in 3T3 
mouse fibroblasts, revealed that cells which are not actively cycling only posses 0-1 
Cajal bodies (Andrade et al., 1993). The number of Cajal bodies per cells is highest in 
mid-to late G1. As the cells progress through S phase and G2, Cajal bodies decrease in 
number and in size and eventually disappear in mitosis (Andrade et al., 1993; Andrade 
et al., 1991). Paraspeckles remain intact throughout mitosis until the cell enters 
telophase (Fox et al., 2002). Paraspeckles are RNA polyermase II transcription-
dependent bodies found adjacent to nuclear speckles during interphase. In early 
telophase, when RNA polyermase II transcription is absent, paraspeckle proteins 
redistribute and form a crescent shaped perinucleolar cap within the nucleolus (Fox et 
al., 2002). As the cells exit mitosis and RNA polymerase II transcription resumes, 
paraspeckles reform in the interchromatin space in close proximity to nuclear speckles 
(Fox et al., 2002). Interestingly, the multiple endocrine neoplasia (Men1) locus shows 
upregulation of two noncoding RNAs, Men ε and Men β, during differentiation of mouse 
muscle cells (Sunwoo et al., 2008). Changes in nuclear organization of paraspeckles 
correlate with upregulated expression of these noncoding RNAs, as foci containing these 
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RNAs are enlarged and more numerous in differentiated myotubes than in myoblasts 
(Sunwoo et al., 2008).   
Nuclear speckles, just like paraspeckles, undergo reorganization during mitosis at 
the onset of nuclear envelope break down (NEBD). At this time, proteins associated with 
nuclear speckles become diffusely distributed throughout the cytoplasm (Ferreira et al., 
1994; Spector et al., 1986). When the cells progress to metaphase, proteins from 
nuclear speckles predominantly remain diffusely distributed in the cytoplasm. During 
metaphase, these proteins start to accumulate in one to three small structures called 
mitotic interchromatin granules (MIGs) that increase in size and number through 
anaphase and early telophase (Ferreira et al., 1994; Leser et al., 1989; Prasanth et al., 
2003; Spector and Lammond, 2010). After mid-to late telophase, following reformation of 
the nuclear envelope and nuclear lamina, localization of pre-mRNA splicing factors to 
MIGs decreases as they enter newly formed daughter nuclei (Prasanth et al., 2003).  
 
1.5 Myogenesis 
Myogenesis is the progression of undifferentiated somite cells to fully differentiated, 
multi-nucleated myotubes. All skeletal muscle arises from mesodermal precursor cells in 
the somite (Molkentin and Olson, 1996). Somite cells themselves are created from the 
segmentation of paraxial mesoderm; furthermore, the somite becomes 
compartmentalized into separate cellular regions in response to signals from the 
notochord and neural tube during embryogenesis (Christ and Ordahl, 1995). Once the 
signals are received, the dorsal portion of the somite, also referred to as the 
dermamyotome, will give rise to the dermis and skeletal muscle (Molkentin and Oson, 
1996). Specifically, induction of myogenesis comes from the notochord and ventral half 
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of the neural tube. The myogenic signal consisting of Wnt and Shh signaling proteins is 
soluble, it is essential for expression of basic helix-loop-helix (bHLH) myogenic 
regulatory factors (MRFs) and it does not require cell-to-cell contact (Buffinger and 
Stockdale, 1995). MRFs posses a conserved basic helix loop helix (bHLH) tertiary 
structure and they all bind to similar sequences of DNA to activate muscle-specific 
genes (Weintraub et al., 1991). The mode of action for MRFs entails heterodimerization 
with E2A gene products followed by binding to the consensus sequence of the E Box 
near the promoter region of muscle-specific genes (Molkentin and Olson, 1996). The E 
box is a DNA sequence typically found upstream of the promoter of genes that is 
recognized for binding of bHLH structural motif of MRFs in order to enhance 
transcription (Chaudhary et al., 1999).  In addition to promoting transcription of muscle-
specific genes, MRFs can physically interact with myocyte enhancer factors (MEFs) to 
activate muscle-specific genes (Molkentin et al., 1995). MRFs have a very potent 
regulatory effect capable of converting many non-muscle cell types into muscle in vitro 
(Choi et al, 1990, Davis et al., 1987, Molkentin and Olsen, 1996). 
Munsterberg and colleagues showed that Wnt 1, Wnt 3, and Wnt 4 cooperate with Sonic 
Hedge Hog (Shh) to induce myogenesis in somites isolated in vitro (Munsterberg et al., 
1995; Molkentin and Olson, 1996). Wnt signaling is mediated by a β-catenin-TCF/LEF-
dependent canonical pathway which directly interacts with MyoD to enhance MyoD 
binding to the E box in the promoters of muscle specific genes (Kim et al., 2008). Within 
the lateral somite, these signals originate from the neural tube and notochord and induce 
the Pax3 transcription factor that in turn activates expression of MRF family members 
MyoD and Myf5 (Muntsberg and Lassar 1995; Weintraub et al., 1991). A schematic 
representation of muscle cell differentiation induction can be found in Figure 1.1.  
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Figure 1.1. Induction of muscle cell differentiation via Wnt and Shh. Signalling 
proteins Wnt and Sonic hedge hog (Shh) originate from the ventral neural tube and 
notochord, respectively, and induce differentiation through activation of MRF family 
members Myf5 and MyoD (Stern et al., 1995). Adapted from Molkentin and Onson, 





Adapted fromMolkentin and Olson, 1996 
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After Pax3 induces expression of MyoD in muscle precursor cells, MyoD-driven 
activation of additional MRFs needed for differentiation is sequestered in proliferating 
myoblasts through direct transcriptional repression and by blocking signaling pathways. 
Within proliferating myoblasts, several proteins and cellular signaling pathways work to 
suppress transcriptional activity of MRFs and myocyte enhancer factors (MEFs). The 
Inhibitor of Differentiation (Id) protein negatively regulates MRFs to inhibit myogenesis; 
specifically, Id will bind and sequester either MRFs or E2A proteins to prevent MRFs 
from binding to the consensus sequence within the E box in the promoter region of 
muscle specific genes (Benezra et al., 1990). Myostatin is another protein involved in 
negatively regulating transcription of MRFs. Specifically, myostatin inhibits the synthesis 
and activity of MyoD (McPherron et al., 1997; Amthor et al., 2004; Guttridge 2004). 
Myostatin is a member of the transforming growth factor-β family and is unique in that it 
negatively regulates both myogenesis and muscle cell proliferation in order to maintain 
muscle homeostasis within an organism. Organisms null for myostatin show increased 
muscle mass due to hypertrophy (McPherron et al., 1997). 
Multiple other signaling pathways are involved in negatively regulating 
myogenesis within proliferating myoblasts.  The Janus kinase signal transducer and 
activator of transcription (JAK-STAT) pathway is a very well characterized pathway that 
is both required for myoblast proliferation and an important checkpoint to prevent 
premature differentiation of myoblasts; furthermore, knockdown of the JAK1-STAT1-
STAT3 pathway induced premature differentiation of myoblasts through induction of 
MyoD and MEF2 and downregulation of Id1 (Luguo et al., 2007; O‟Shea et al., 2002). 
The Stau1 pathway is also involved in negative regulation of myogenesis (Yamaguchi et 
al., 2008), as knockdown of Stau1 enhanced myogenesis. Cells depleted of 
Stau1showed an increase in myogenin promoter activity, indicating that Stau1 may work 
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to inhibit an event directly prior to activation of the myogenin promoter (Yamahuchi et al., 
2008). Stau1 also inhibits myogenesis through association with the UPF-1 protein, which 
is a component of mRNA decay machinery that attacks MyoD mRNA (Yamaguchi et al., 
2008). Another signaling pathway, the notch pathway, inhibits myogenesis through 
repression of MyoD (Buas and Kadesch 2010; Kopan et al., 1994). Ectopic expression of 
notch inhibits differentiation of C2 myoblasts upon serum deprivation and stops the 
conversion of 3T3 cells transfected with expression vectors driving Myf5 or MyoD 
expression. Furthermore, evidence indicates that notch expression does not stop the 
binding of E proteins to the E box-binding site within MyoD, but rather targets the bHLH 
region of MyoD following heterodimerization  (Kopan et al., 1994).  
In order for myoblasts to differentiate, they must withdraw from the cell cycle 
(Molkentin and Olson, 1996). Withdrawal from the cell cycle and subsequent 
transcription of muscle-specific genes requires the removal or depletion of fibroblast 
growth factors (FGFs) in the surrounding environment (Menko and Boettiger, 1987). 
After FGFs are absent from the environment, several proteins associated with the cell 
cycle and cell cycle progression is modified in terms of structure and/or expression 
levels to promote cell cycle withdrawal and differentiation. For example, the 
retinoblastoma (Rb) protein is phosphorylated in proliferating cells to sequester it and its 
growth-inhibiting activity; however, when FGFs are depleted, the Rb protein is 
dephosphorylated and becomes active (Molkentin and Olson, 1996; Weinberg, 1995). 
Rb then sequesters the E2F family of transcription factors that directly activate the 
expression of several genes required for cell proliferation (Weinberg 1995). MRFs are 
suppressed in proliferating myoblasts, and forced expression of these proteins inhibits 
cell cycle progression, suggesting that MRFs and proteins associated with cell cycle 
progression modify each other‟s activities (Molkentin and Olson, 1996) as exemplified by 
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the relationship between cyclin D1, Rb, Cdk inhibitor 21, and MRF proteins. In 
proliferating myoblasts, cyclin D1 suppresses Rb and allows for progression of the cell 
cycle, specifically at the G1-S transition. Furthermore, cyclin D1 inhibits MyoD-mediated 
transcriptional activation of MRFs (Skapek et al., 1995; Molkentin and Olson, 1996). 
After myoblasts receive the signal to differentiate, Cdk inhibitor p21 is upregulated and 
suppresses cyclin D1 (Skapek et al., 1995). When cyclin D1 is inhibited, Rb and MyoD 
are no longer sequestered and can inhibit cell cycle progression and allow activation of 
MRFs respectively (Skapek et al., 1995; Guo et al., 1995). Figure 1.2 summarizes these 
interactions.  
When differentiation is induced and cell cycle progression is halted, expression of 
muscle-specific genes is upregulated, further directing myoblasts along the 
differentiation program. In addition to MyoD and Myf5, the MRF family of proteins 
consists of Myogenin and Myf4, which also play crucial roles in ensuring terminal 
differentiation of myoblasts (Weintraub et al., 1991). Following activation of the MRFs 
myogenin and Myf4, myogenin is likely to cooperate with MyoD and Myf5 to activate 
muscle contractile genes such as myosin heavy chain (MHC) (Lassar et al., 1991). 
During differentiation, expression and activity of MRFs is positively regulated through a 
number of proteins and pathways. For example, the half-lives of MyoD, myogenin, and 
p21 mRNAs are extended during myogenesis (Myer et al., 1997; Kao et al., 1994). 
Proteins HuR and NF90 both work to bind to the Au-rich element of the 3‟ untranslated 
region (3‟ UTR) of muscle-specific transcripts to protect against degradation (Myer et al., 
1997; Kao et al., 1994). A protein called titin-cap (TCAP) positively regulates 
myogenesis through interaction with myostatin. When TCAP is knocked down via RNA 
interference, the expression of MyoD and myogenenin also decreases (Nicholas et al., 
2002). Another protein, numb, works to promote myogenesis through inhibition of the  
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Figure 1.2. Interaction between MRFs and cell cycle progression-related proteins. 
MRFs and proteins involved with cell cycle progression modify each other‟s activities. In 
proliferating myoblasts cyclin D1 supresses Rb and MyoD-mediated transcriptional 
activation of MRFs. In differentiating myoblasts, Cdk inhibitor p21 inhibits cyclin D1 and 







Adapted from Molkentin and Olson, 1996 
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notch signaling pathway (Buas and Kadesch 2010). During endocytic trafficking, notch 
can be sent to the early endosome for recycling in the cell or sent to the late endosome 
for degredation. Overexpression of numb followed by surface biotinylation and trafficking 
assays revealed that in the presence of numb, notch is preferentially sent to the late 
endosome for degredation indicating that numb inhibits the notch signaling pathway 
through endocytosis (McGill et al., 2009).   
After myoblasts receive the signal to terminally differentiate, myoblasts will align into a 
chain-like formation in preparation of fusion to become the multi-nucleated myotube 
(Knudsen, 1985). Cellular fusion within myogenesis is actually divided into two stages; 
the first consisits of myoblasts fusing with other myoblasts, and the second involves 
myoblasts fusing to existing myotubes (Rochlin et al., 2010). The alignment process is 
mediated by cellular membrane glycoproteins including several cadherins and cell 
adhesion molecules (CAMs). Furthermore, this process requires that neighboring cells 
participating in the fusion event are all myoblasts (Knudsen et al., 1990). In order for 
myoblasts to become aligned, they must first migrate towards one another. The actin 
cytoskeleton is crucial in facilitating migration of myoblasts. Myoblasts treated with 
latrunculin A or cytochalasin D (that interfere with F-actin) exhibit hindered myoblast 
migration (Coue et al., 1987; Dhawan and Helfman, 2004; Nowak et al., 2009; 
Constantin et al., 1995; Sanger and Holtzer, 1972). Once myoblasts are aligned, cellular 
membranes are dissolved and multiple myoblasts join together to form one 
multinucleated myotube (Konigsberg, 1963; Mintz and Baker, 1967). Different proteins 
are involved in myoblast-to-myoblast fusion than are involved in myoblast-to-myotube 
fusion (Rochlin et al., 2010). Proteins including β1-integrin, VLA-4, VCAM, and caveolin-
3 are involved in myoblast-to-myoblast fusion (Schwander et al., 2003; Rosen et al., 
1992; Galbiati et al., 1999). The NAFTC2 pathway activated by calcium, calmodulin, and 
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IL-4 cytokine is involved in regulating myoblast-to-myotube fusion (Rochlin et al., 2010). 
 In summary, there is a relatively clearly defined molecular pathway for muscle 
cell differentiation and for regulation of gene expression during myogenesis. The 
proteins involved in the molecular pathways leading to muscle cell differentiation provide 
an excellent roadmap of cellular markers that can be used to understand how proteins 
that have not previously been assigned any functions in muscle cells might participate in 
muscle cell differentiation. Within this study, we used key proteins and morphological 
states (namlely myogenin, myosin heavy chain (MHC), and mulitinucleation) to study 
how Bcl-2- associated transcription factor (Btf) functions might possibly participate 
muscle cell differentiation. Using a combination of immunofluorescence labeling of Btf as 
well as myogenin and MHC and western blot analysis, we have studied the labeling and 
relative expression levels of Btf throughout the differentiation time course using a C2C12 
mouse myoblast cell line.  
1.6 Nuclear Organization and Muscle Cell Differentiation  
 Cellular differentiation requires a vast shift in gene expression. Given that nuclear 
structure is functionally related to gene expression, it stands to reason that a shift in 
gene expression would lead to a shift in nuclear structure. Recent studies indicate that 
genome architecture is dynamic and varies with the cell cycle and physiological state of 
the cell (Ferguson and Ward, 1992; Vourch‟h et al., 1993; Nagase et al., 1996; Brero, et 
al., 2005).  During cellular differentiation, genes that have been previously silenced 
through repressive conformations imposed by nucleosomes must be made accessible to 
transcription factors (Cairns, 2009). Nucleosome-enforced repression can be overcome 
by a combination of tissue-specific transcription factors and multi-subunit machineries 
that remodel nucleosomes (Berkes and Tapscott, 2005). In the case of myogenesis, 
MyoD and Myf5 must be able to bind the E box within the promoter regions of muscle-
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specific bHLH genes such as myogenin and Myf4 (Berkes and Tapscott, 2005). A 
combination of physical and functional interactions between bHLH proteins and 
SWI/SNF chromatin remodeling complexes allow for the rearrangement of nucleosomes 
to remodel the chromatin in way that favors transcriptional access of MyoD and Myf5 to 
muscle-specific bHLH and MEF2 factors (de la Serna et al., 2001; Simone et al., 2004). 
The SWItch/Sucrose NonFermentable (SWI/SNF) is an ATP-dependent chromatin 
remodeling unit which consists several proteins that are products of the SNF and SWI 
genes as well as two main catalytic subunits, Brg1 and Brm (de la Serna et al., 2001; 
Simone et al., 2004; de la Serna et al., 2006). In addition to catalytic subunits, different 
combinations of noncatalytic subunits including Brg1/Brm-associated factors (BAFs) 
provide the SWI/SNF complex with molecular variability allowing the complex to 
selectively interact with different tissue-specific transcription factors and other chromatin-
remodelling enzymes (Wu et al., 2009). The mechanism by which the SWI/SNF complex 
remodels chromatin involves altering the position of nucleosomes along the DNA 
through ATPase activity that works to destabilize DNA-histone interactions; however, the 
exact change in structure is unknown (Pazin et al., 1997; Whitehouse et al., 1999). In 
addition to general chromatin remodeling, Chaly and Munro studied localization of 
centromeres during myogenesis in vitro using a L6E9 rat myoblast cell line (Chaly and 
Munro, 1996). During myogenesis, centromeres relocated to the nuclear periphery; 
furthermore, condensed chromatin was more prevalent at the myotube nuclear envelope 
as observed by electron microscopy (Chaly and Munro, 1996). Regions of 
heterochromatin also display a spatial clustering that is reliant on histone deacetylase 
(HDAC) activity (Terranova et al., 2005). However, characterization of nuclear 
organization of other nuclear domains during muscle differentiation is limited, and our 
project aimed to observe changes in nucleoli and nuclear speckles relative to the 
differentiation timeline in C2C12 cells.  
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1.7 Bcl-2 Associated Transcription Factor 
Several nuclear speckle proteins have recently gained attention due to unique 
domain structure and/or suggested functions.  One of the non-classical SR proteins 
identified in a proteomic analysis of purified mouse nuclear speckles was Bcl-2 
associated transcription factor (Btf) (Saitoh et al., 2004). Btf showed some colocalization 
with splicing factors in nuclear speckles, and it has an RS domain; however, the RS 
domain in Btf is located at the N-terminus rather than the C-terminus where it is typically 
found in classical SR proteins (Saitoh et al., 2004; Mintz et al., 1999). Btf is a 
transcription repressor that, when overexpressed, induces apoptosis through inhibition of 
the anti-apoptotic Bcl-2 protein family (Kasof et al., 1999; Haraguchi et al., 2004). 
Interestingly, Btf is expressed at high levels in skeletal muscle (Haraguchi et al., 2004; 
Nagase et al., 1996). Previous evidence suggests that Btf may associate with emerin, 
(Haraguchi et al., 2004; L. Ford and P. Bubulya, unpublished data), a 34kDa, 254-amino 
acid, serine-rich inner nuclear envelope protein (Haraguchi et al., 2004; Fairley et al., 
1999).  
Emerin is thought to possibly regulate mechanosensitive and stress-induced genes, 
contributing to overall muscle maintenance and integrity  (Fairley et al., 1999; Ostlund et 
al., 1999). In addition to Btf, emerin binds to lamins A and C, lending structural integrity 
to the cell according to the Structural Hypothesis (Salpingidou et al., 2007). The 
Structural Hypothesis proposes that the network of emerin and lamins serve as the load-
bearing center of the nuclear envelope, and that bridging complexes span the nuclear 
envelope connecting the inner nuclear membrane with the actin cytoskeleton 
(Hutchinson et al., 2002; Crisp et al., 2006). Muscle cells null for emerin undergo cell 
death and eventual muscle wasting; furthermore, a number of emerin mutations have 
been associated with Emery-Dreifuss Muscular Dystrophy (Broers et al., 2004, 
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Salpinidou et al., 2007). Select mutations in emerin that have been associated with 
EDMD occur within the region of emerin that associates with Btf (Salpinidou et al., 
2007). Although emerin with such naturally occurring mutations (for example, a serine to 
phenylalanine substitution at residue 54 (S54F), a proline to histidine substitution at 
residue 183 and a proline to threonine substitution at residue 183) demonstrated normal 
levels and localization (Haraguchi et al., 2004), One might predict disrupted Btf-emerin 
association, that could lead to altered function in muscle cells. Based on the supposed 
interaction of Btf and emerin and Btf‟s putative role in EDMD, we wish to investigate a 
possible role for Btf in muscle cells.  However, because the behavior of nuclear speckles 
and constituent proteins is poorly characterized during muscle cell differentiation, we set 

















Chapter 2: Hypothesis and Experimental Amis 
 Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive disorder 
causing progressive muscle wasting, cardiomyopathy, and a deformation of muscular 
tissue in the elbows, Achilles tendon, ankles, and spine (Emery 1989). Sudden death 
resulting from cardiac defects can be averted with early diagnosis and pacemaker 
placement; however, there is no treatment for the accompanying muscle wasting (Ellis et 
al. 1999). Most EDMD patients are null for the nuclear protein emerin resulting from 
nonsense mediated decay (Haraguchi et al., 2004). Emerin is a 34kDa, 254 amino acid, 
and serine rich, nuclear envelope protein; furthermore, emerin is predicted to be a type II 
membrane protein possessing a transmembrane region (Haraguchi et al., 2004; Fairley 
et al., 1999). Emerin is thought to possibly regulate mechanosensitive and stress-
induced genes, contributing to overall muscle maintenance and integrity (Fairley et al., 
1999; Ostlund et al., 1999).  A subset of EDMD patients demonstrate normal amounts 
and localization of emerin at the inner nuclear membrane in contrast to most EDMD 
patients whom produce no detectable emerin as observed by immunoblotting and 
immunohistochemistry; furthermore, all of these mutations that produce seemingly 
“normal” emerin occur within regions of emerin which associate with Btf (Haraguchi et 
al., 2004; Fairley et al., 1999). This set of mutations includes a serine to phenylalanine 
substitution at residue 54 (S54F), a proline to histidine substitution at residue 183 and a 
proline to threonine substitution at residue 183 (Haraguchi et al., 2004).  
 Based on the supposed interaction of Btf and emerin as well as Btf‟s putative role 
in EDMD, we investigated a possible role for Btf in muscle cells using a C2C12 mouse
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myoblast cell line. C2C12 differentiation in our hands reflected timing and gross 
morphological changes seen previously (Konigsburg, 1963; Mintz and Baker, 1967; 
Lassar et al., 1989). This is important because it allowed likewise comparison of our data 
and data of other labs which have done work on muscle cell differentiation in C2C12 
cells. Preliminary experiments revealed that Btf was upregulated during differentiation as 
observed by immunoflourescence microscopy and immunoblotting (Figure 2.1) 
(Theadore Hufford, Alok Sharma and Paula Bubulya, unpublished data). I performed 
differentiation time course experiments in which I immunolabled Btf and muscle specific 
proteins which validated observations made by an undergraduate honors student who 
had only done the experiment once. I therefore hypothesized that increased expression 
of Btf may be important for muscle cell differentiation. In order to test this hypothesis, I 
designed experiments in which Btf was overexpressed and experiments in which Btf was 
depleted. Given that Btf is upregulated during differentiation, I overexpressed Btf in 
undifferentiated C2C12 cells to determine if overexpression of Btf could induce 
differentiation or possibly expedite the differentiation time course as compared to C2C12 
cells undergoing a normal differentiation time course induced by serum deprivation. 
Controls were included to assert that transfection alone was not altering differentiation, 
that transfected cells could indeed differentiate, and that timing of differentiation in 
transfected samples which were either induced or not induced to differentiate matched 
the timing  of untransfected samples maintained in the same conditions. Given that Btf is 
upregulated during differentiation, I also designed experiments to deplete Btf in C2C12 
cells and induce differentiation to determine if C2C12 cells depleted of Btf could undergo 
normal differentiation. siRNA was utilized for Btf depletion and differentiation via serum 
deprivation was induced 24 hours following siRNA treatment. Cells treated with siRNA 
buffer alone, siRNA oligs targeted against luciferase, as well as untransfected cells were 
used as controls.  
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Figure 2.1. Western blot analysis to detect expression of nuclear and muscle 
specific proteins during differentiation of C2C12 myoblasts. WCNE was prepared 
on each day of the differentiation time course. Equal total protein in each sample was 
loaded onto SDS-PAGE and transferred to a nitrocellulose membrane for 
immunoblotting. Upon stimulus to differentiate, expression of muscle-specific gene 
myogenin was increased at Day 1 and MHC expression was increased at Day 2. Btf 
expression is detectable at Day 1 and increases through Day 4 of the differentiation time 
course. Nuclear speckle protein SF2/ASF also show increased in expression between 
Day 0 and Day 1. Actin was used as an equal loading control. Western Blot was 







In addition to Btf upregulation during C2C12 differentiation, preliminary experiments 
showed surprising nuclear reorganization. To investigate this further, I did differentiation 
time course experiments in which I observed nuclear domains. My results substantiated 
observations made by an undergraduate honors student who had only done the 
experiment once. I therefore proposed that muscle cell differentiation as observed in 
C2C12 cells resulted in reorganization of nuclear domains. To test this hypothesis, I 
designed experiments to investigate nuclear speckle and nucleolar organization 
throughout the differentiation process as well as experiments to assert that the observed 
nuclear reorganization was not a result of serum starvation. To observe nuclear speckles 
and nucleoli during the differentiation process, I performed differentiation time course 
experiments in which I immunolabeled for nuclear speckle protein Son or nucleolar 
protein fibrillarin as well as muscle specific proteins myogenin and MHC.  I also 
performed serum starvation experiments with HeLa and MEF cells to confirm that the 
nuclear reorganization observed in differentiating C2C12 cells was not a result of serum 
starvation or a muscle specific phenomenon. Throughout differentiation, both nuclear 
speckles and nucleoli change in morphology from diffuse and less enriched bodies to 
more punctuate and enriched bodies; therefore, I hypothesized that nuclear domains 
most likely reorganize in one and/or two ways. One proposed method is that nuclear 
domains fuse during differentiation and the other possibility is that some nuclear 
domains recede while others enlarge (Figure 2.2). To test this hypothesis, I designed 
experiments to image nucleoli in differentiating C2C12 cells live. I performed 
experiments to optimize transfection of CFP-fibrillarin plasmid DNA via electroporation 
and experiments to determine the optimal time for imaging to capture the change in 




Figure 2.2. Proposed model for nuclear reorganziation as observed in 
differentation of C2C12 myoblasts. Two modes of action were proposed to describe 
the change in nuclear organization. The first model suggests that multiple domains fuse 
together over time, while the second models suggests that certain nuclear domains 








































I hypothesized that Btf is important for muscle cell differentiation and muscle cell 
differentiation results in nuclear reorganization. My specific experimental aims were as 
follows: 
Aim I.  
Investigate effects of Btf overexpression and depletion on C2C12 
differentiation.  
 
Aim II.  
Characterize the nuclear reorganization events that occur during muscle 


















Chapter Three: Materials and Experimental Methods 
3.1 Cell Culture 
C2C12 cells (ATCC) were passaged for three days to expand the culture. Frozen 
stocks of equal passage number (passage 4) were stored at -80°C for all experiments. 
C2C12 and mouse embryonic fibroblast (MEF) cells were maintained in growth medium 
(GM) which consisted of Dulbecco‟s Modified Eagles Medium (DMEM) supplemented 
with 15% Fetal Bovine Serum and 1% penicillin/streptomycin (50:100 units penicillin, 
50:100 μg streptomycin; Invitrogen) (Growth Medium, GM). HeLa cells were maintained 
in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. All cells were 
kept in a humidified 37°C incubator injected with 5% carbon dioxide. For each 
experiment, a fresh vial of C2C12 cells was thawed, plated in a 100mm x 20mm culture 
dish and grown for approximately 36 hours until the cells reached 60-70% confluency. 
MEF and HeLa cells were grown in 100mm x 20mm culture dishes and were passaged 
when the cells obtained 70-80% confluency. To passage MEF and HeLa, cells were first 
briefly washed three times with phosphate buffered saline (PBS; 137 mM NaCl; 2.7 mM 
KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4, pH 7.4). Following washing, the cells were 
incubated with trypsin-EDTA (Invitrogen; 0.25% trypsin solution) for 3 minutes at 37°C 
with minimal agitation. Approximately 5 mL of DMEM + 15% FBS was added to 
inactivate the trypsin, and the suspension was transferred to a 15 mL conical tube and 
centrifuged at 1500 rpm for 2 minutes. The supernatant was removed by aspiration and 
the pellet was resuspended with 5 mL of DMEM + 15% FBS. The cells were then either 
plated into fresh 100 mm x 20 mm culture dishes or counted and plated into well dishes
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for experiments.  
 
3.2 Plating Cells 
To plate cells for differentiation time courses, siRNA depletion experiments, YFP-
fusion protein overexpression experiments and all other experiments, the cells were first 
collected from the 100 mm x 20 mm culture dishes, centrifuged, and resupsended as 
previously described. Ten microliters of the cell suspension was loaded onto each side 
of a Bright-Line Hemocytometer and the cells were counted and averaged to determine 
cell concentration. Cells were diluted to the appropriate concentration with DMEM+ 15% 
(for C2C12)or 10% FBS (for HeLa or MEF) and plated in wells with coverslips for 
processing for immunofluorescence and live cell imaging, or without coverslips for 
protein and RNA extraction.  For all differentiation time course studies, 2x105 C2C12 
cells were plated in 35mm dishes. For all MEF and HeLa immunofluorescence 
experiments, 1x105 cells were plated in 35mm dishes. For siRNA experiments, 1x105 
C2C12, MEF, and HeLa cells were plated in each well of 24-well dishes. For live cell 
imaging optimization experiments, 2.5x105 C2C12 cells were plated onto each well of a 
6-well dish. For live imaging, 5x105 C2C12 cells were plated into each 60 mm x 15 mm 
dish.  
3.3 Coverslip Preparation 
 All coverslips were cleaned thoroughly by washing in one part nitric acid and two 
parts hydrochloric acid for approximately 2 hours with occasional stirring; continuous 
rinsing in distilled water was done until the pH returned to approximately 7.0. The 
coverslips were then stored in 70% ethanol and flamed prior to use. Coverslips to be 
used with C2C12 cells were treated with 0.001% Poly-L-lysine (Sigma) for five minutes 
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at room temperature. The mixture was removed by aspiration, the coverslips were dried 
for 30 minutes at room temperature, and washed three times for 5 minutes each with 
PBS at room temperature. The coverslips were either used immediately or stored at 4°C.  
3.4 Induction of C2C12 Differentiation 
C2C12 differentiation was induced via serum deprivation or self-induction through 
cell-to-cell contact (Yaffe and Saxel, 1977). For induction of differentiation using serum 
deprivation, the cells were plated one day prior to inducing differentiation (Day -1) in GM. 
Differentiation was induced on Day 0 of the time course by removing GM and washing 
briefly three times with PBS to remove any remaining GM. Differentiation was then 
induced with the addition of differentiation medium (DM) consisting of DMEM 
supplemented with 2% Horse Serum and antibiotics streptomycin and penicillin. For self-
induction of C2C12 differentiation, cells were plated at 3.5x105 C2C12 in 35mm dishes. 
Cells were maintained in GM throughout the entire differentiation time course and GM 
was replenished every 48 hours. Cells were monitored daily for the formation of 
myotubes as an indication that differentiation was proceeding normally.  
3.5 Immunofluorescence 
C2C12 cells were washed briefly three times with PBS and fixed with 2% 
formaldehyde (2 grams paraformaldehyde dissolved into 100 mL PBS) for 15 minutes at 
room temperature. Cells were washed 3 x 5 minutes with PBS. Cells were permeabilized 
with 0.2% Triton X-100 in PBS for 10 minutes and washed 3 x 5 minutes in PBS + 0.5% 
normal goat serum (NGS; Gibco) at room temperature. Cells were incubated  with 
primary antibodies  WU10 (anti-Btf, 1:1000), WU13 (anti-Son, 1:1000), human anti-
nucleolar antibody (anti-fibrillarin , 1:500; Sigma Aldrich, St. Louis, MO), monoclonal F5D 
(anti-myogenin,1:500; University of Iowa Developmental Studies Hybridoma Bank, Iowa 
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City, IA), monocolonal MF20 (anti-MHC, 1:1000; University of Iowa Developmental 
Studies Hybridoma Bank, Iowa City, IA), monocolonal anti-fibrillarin (1:500; Abcam, 
Cambridge, MA), and anti-Asym 25 (1:100, provided by Jocelyn Cote, University of 
Ottowa, Ottowa, Ontario) for 1 h at room temperature in a humidified chamber. Cells 
were washed 3 x 5 minutes with PBS + 0.5% NGS and incubated with either FITC-, 
Texas Red-, or Cy5-conjugated secondary antibodies (1:2000; Jackson 
Immunoresearch Laboratory) for 1 h at room temperature in a dark, humidified chamber. 
Cells were washed once in PBS + 0.5% NGS, then with PBS + DAPI (10μg/ml) in PBS in 
the second wash. Coverslips were mounted using 12 µl of mounting medium containing 
anti-fade (polyphenylinediamine), sealed with nail polish, and stored at -80°C. HeLa cells 
were processed the same as C2C12 cells with the exception that permeabilization was 
performed for 5 minutes. MEFs were also processed the same as C2C12 cells but 
fixation was done with 4% formaldehyde.  
3.6 Microscopy 
The cells were imaged used a DeltaVision RT real time restoration system (Applied 
Precision) with PLAN-APO oil, 1.4 N.A. objectives (Olympus). C2C12 cells were imaged 
with a 40x objective lens and MEF and HeLa cells were imaged with a 60x objective 
lens. Images were obtained with a cool snap CCD camera and SoftWorx Explorer Suite 
was used for visualization and processing. Z-stacks consisting of 0.2 µm increments 
through the z-plane of the cells were displayed as a volume projection to include all 
images from the z-stack of interest. For live imaging, z-stacks were collected at 30 
minute intervals in 0.30 µm increments throughout the entire depth of all C2C12 nuclei 




3.7 Whole Cell Nuclear Extract Preparation 
       C2C12 cells for immunoprecipitation experiments were extracted using the whole 
cell nuclear extract (WCNE) protocol established by Wysocka et al. (2003). The cells 
were removed from the plate by applying PBS to the cells and scraping using a rubber 
policeman. The cells were then placed in an eppendorf tube and centrifuged for 5 
minutes at 1200 rpm. Lysis buffer [300mM NaCl, 100mM Tris (pH 8.0), 0.2mM EDTA 
(pH 8.0), 0.1% NP40, 10% glycerol and protease inhibitor cocktail (Pierce, 1 tablet per 
10 ml of lysis buffer added freshly prior to cell extraction] was added to the pellet and 
incubated at 4°C on a tube rotator. After incubation with lysis buffer, the extract was 
centrifuged for 10 minutes at 14,000 rpm at 4°C and the supernatant was collected and 
stored at -80ºC.  
3.8 Protein Extraction, Bradford Assays, and SDS-PAGE 
Cells were washed with PBS and scraped from the dish using 1ml of PBS and a rubber 
policeman. The wells were then washed with additional PBS, the samples were 
collected, centrifuged at 4°C for 5 minutes in a clinical centrifuge at 1200 rpm, the 
supernatant was removed, the pellet washed with additional PBS, and the samples 
centrifuged again for 1 minute. The supernatant was removed, the pellet was 
resuspended with 50-100 µl of RNase-free water,  an equal volume of 2x Laemmli buffer 
(4% SDS, 20% glycerol, 1.4M β-mercaptoethanol, 0.125 M Tris HCl, and bromophenol 
blue) was added, and the samples were stored at -80°C. Before Bradford Assays were 
performed, the protein samples were boiled for 5 minutes to denature the proteins. For 
the Bradford Assays, standards of 1µg, 2µg, 5µg, 10µg, and 20µg of BSA were prepared 
in distilled water in a total volume of 4µl. 2µl of cell extract was mixed with distilled water 
for a total volume of 4µl. 496µl of water and 500µl of Thermo Scientific Coomassie Plus 
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Protein Assay Reagent were then added for a final volume of 1mL. Samples were 
loaded into 1 mL cuvettes and absorbance was measured at λ495 on a Milton Roy 
Spectronic 1001 Plus. A graph of OD versus µg protein was plotted with the standard 
samples and a best fit line was applied. Once protein concentrations of experimental 
samples were determined using absorbance readings and the standard curve, 40ug of 
each sample was loaded into the wells of a 10% or 15% poly-acrylamide gel [resolving 
gel: 10% or 15% Degassed acrylamide/bis, 0.125 M Tris HCl (pH 8.8), 0.1% SDS; 
stacking gel: 10% Degassed acrylamide/bis, 0.125 M Tris HCl (pH 6.8), 0.1% SDS], and 
gel electrophoresis was performed in Running Buffer [30 mM Tris HCL, 144 mM glycine, 
0.01% SDS] at 150 V for approximately one hour. Precision Plus protein ladder 
purchased from BioRad served as the molecular mass marker. The proteins were then 
transferred from the polyacrylamide running gel to a nitrocellulose membrane at 200 mA 
for 90 minutes using chilled Transfer Buffer (Running Buffer containing 20% methanol). 
Ponceau (0.5% Ponceau S, 1% acetic acid) staining was used to confirm successful 
transfer and to mark well lanes and marker. The nitrocellulose membrane was blocked 
to avoid non-specific binding of antibodies using PBST [0.22 M sodium phosphate 
monobasic, 1.2 M sodium phosphate dibasic anhydrous, 137 mM sodium chloride, and 
1.0% Tween] and 5% non-fat dry milk. The membrane was then cut horizontally to 
separate the region of the membrane with the protein of interest and the protein used as 
equal loading control to allow for dual probing. Primary antibodies were diluted in 5% 
non-fat dry milk in PBST, applied to the membrane, and incubated for 1 hour at room 
temperature.  The membrane was washed 3 x 5 minutes with PBST on a shaker, and 
species-specific antibodies conjugated with horseradish peroxidase (HRP) diluted in 
PBST + 5% nonfat dry milk were applied to the membrane and incubated for 1 hour at 
room temperature on a shaker. The membrane was washed 3 x 5 minutes with PBST 
the membrane was developed using Thermo Scientific Pierce ECL Western Blotting 
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Substrate. The blot was then imaged on Fuji LAS- 4000 Luminescent Image Analyzer 
(Fujifilm Life Science USA, Stamford, CT).  
3.9 RNA Extraction  
 Cells to be harvested for RNA extraction were plated as described above. All 
RNA extractions were performed using Qiagen RNeasy reagents and supplied protocols. 
DMEM was removed from cells and collected in 15 ml conical tubes. The cells were 
washed briefly with PBS, incubated with trypsin, collected using 1 mL DMEM, and 
centrifuged for 2 minutes in a conical centrifuge at 1500 rpm. The supernatant was 
removed, the pellet was washed with PBS, the samples were centrifuged again for 2 
minutes in a conical centrifuge at 1500 rpm, and supernatant was removed. Pellets were 
resuspended with 350ul of Qiagen RNeasy RLT buffer and vortexed for 1 minute. 350µl 
of 70% ethanol was added and 700 µl of the sample was loaded into a RNeasy spin 
column and centrifuged for 15 seconds at 1600 rpm. 700 µl of Qiagen RNeasy RW1 
buffer was added to the column and centrifuged as before. 500ul of Qiagen RNeasy 
RPE buffer was added to the column, centrifuged as before, and an additional 500ul of 
RPE buffer was added to the column and centrifuged for 2 minutes at 1600 rpm. To 
elute the RNA, 30µl of RNase-free water was applied directly to the spin column 
membrane and centrifuged for 1 minute. This step was repeated and the eluted RNA 
was stored at -80°C.  
3.10 Midi Prep and Restriction Digest of Plasmid DNA Preparation 
 All plasmid preparations were done with Promega‟s Wizard‟s® Plus Midipreps 
DNA Purification System. Plasmid DNA for transfection was isolated from glycerol stocks 
of E. coli cultures containing respective plasmids that were prepared by previous lab 
members. E. coli from glycerol stocks was added to 3 mL cultures of sterile LB Broth 
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supplemented with 1 µl/mL of either ampicillin or kanamycin as appropriate for each 
plasmid and incubated overnight in an orbital shaker at 37°C. 2mL of the 3mL overnight 
suspension was added to 100 mL of sterile LB Broth and incubated as before. The 100 
mL culture was transferred to a sterile 250 mL centrifuge tube and centrifuged at 10,000 
RCF‟s for 10 minutes at 4°C and the supernatant was removed. The pellet was 
resupsended in 3 mL of Promega Resuspension Buffer, followed by 3 mL of Promega 
Lysis Buffer and finally 3 mL of Promega Neutralization Buffer. The suspension was 
centrifuged again at 14,000 RCF‟s for 15 minutes and the supernatant was decanted 
through filter paper into a fresh 50mL Falcon tube. 10mL of Promega Purification Resin 
was added to the supernatant, then the mixture was transferred into a Promega Midi-
prep column and a vacuum source was applied. The DNA-bound resin was washed 
twice with 15 mL of Promega Wash Buffer. DNA was eluted with 300 µl of 65-70°C 
RNase-free water. The DNA was then precipitated out by adding 30 µl of 3.0mM sodium 
acetate and 900µl of 95% ethanol and incubated at -20°C for at least four hours. The 
DNA was then centrifuged at 1600 rpm for five minutes, the supernatant was removed, 
and the pellet was washed with 95% ethanol, and centrifuged again as described above. 
The supernatant was removed and the pellet was allowed to dry, 200 µl TE was added 
to dissolve the DNA. DNA was then quantified using ND-1000 Spectrophotometer 
NanoDrop. Plasmid identity was confirmed by digesting DNA with appropriate restriction 
enzymes at 37ºC for two hours. 6x loading dye was added to each digested plasmid 
sample and loaded onto an 1% agarose gel containing ethidium bromide and run at 70V 
for 1 hour.  Gels were then imaged using a Fotodyne camera with an ethidium bromide 





3.11 Transfection of DNA by Electroporation  
 C2C12 cells were cultured, collected, and counted as previously described. Cells 
were resuspended in electroporation buffer [EB; 1x HBS, 5uM CaCl] at a concentration 
of 5x105 cells per 250 µl of EB.  Appropriate concentrations of plasmid DNA and salmon 
sperm DNA (see chart below) were added to each 4 mm gap cuvette and incubated for 
one minute and then 250 µl of cells in EB were added to each cuvette.  
 
Plasmid µg of Plasmid DNA µg of Salmon Sperm DNA 
CFP-Fibrillarin 4 80 
YFP-Btf 4 80 
YFP-SF2 4 60 
 
C2C12 cells were electroporated using a BioRad GenePulser XCell [220V, 950µF, and 
0Ω]. Cells were incubated on ice for 10 minutes post-electroporation, resuspended in 1 
mL of DMEM per cuvette, and plated.  
3.12 RNA Interference  
Cells were plated as previously described in antibiotic-free DMEM supplemented with 
10% FBS. siRNA transfection was done 24 hours after cells were plated. HeLa and 
C2C12 cells were transfected using Gibco 1x Opti-MEM, Invitrogen Oligofectamine 
Reagent, Dharmacon 1x siRNA buffer, 20µM Luciferase oligo [Dharmacon],  and 20 µM 




Condition Tube 1 Tube 2 
Mock 15µl Oligofectamine 250µl Opti-MEM 
60µl Opti-MEM 15µl siRNA Buffer 
Control 15µl Oligofectamine 250µl Opti-MEM 
60µl Opti-MEM 15µl 20µM Luciferase oligo 
Mouse si-1siRNA duplex 15µl Oligofectamine 250µl Opti-MEM 
60µl Opti-MEM 15µl 20µM msi-1 
Human si-2 siRNA duplex 15µl Oligofectamine 250µl Opti-MEM 
60µl Opti-MEM 15µl 20µM hsi-2 
 
Contents were added to each tube and incubated for 5 minutes at room temperature. 
Contents of Tube 2 were added to Tube 1 and incubated for 20 minutes at room 
temperature. 340 µl of each mixture was added to appropriate wells. HeLa and C2C12 
cells were incubated for 24 hours and then processed. For C2C12 differentiation time 
course studies, differentiation was induced via serum deprivation (in DM) 24 hours post-
transfection. Mock, control, msi-1, and hsi-2 samples were processed at Day 0, Day 2, 
and Day 4 of the differentiation time course for immunofluorescence, protein extraction, 
and RNA extraction.  
 
3.13 Live Cell Microscopy 
C2C12 were cultured, plated, and electroporated as described above. Differentiation 
was induced  in DM 12 hours post-transfection and imaging began ~30 hours into the 
differentiation time course. The coverslip was removed from GM and loaded onto the live 
cell chamber apparatus and perfused with Leibovitz‟s L-15 Medium (Invitrogen) 
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supplemented with 2% HS. Cells were imaged with the DeltaVision RT system using 
point visiting every 30 minutes for 8 hours using CFP and YFP channels. Images were 
displayed as time-lapse videos.  
3.14 Nucleoli and Mitotic Counts 
Nucleoli counts were performed on fixed cells processed by immunofluorescence for 
visualization of fibrillarin. For C2C12 cells, 50 myoblast nuclei and 50 myotube nuclei 
were randomly selected by blindly selecting areas of the coverslip for image capture. 
Each nucleus selected was then scored for the number of nucleoli present as indicated 
by fibrillarin staining. MHC or myogenin-negative cells were scored as undifferentiated 
cells. Cells positive for MHC or myogenin were scored as differentiating cells. These 
counts were done for each day of the differentiation time course. These counts were 
done for three separate time courses, the counts were averaged, and standard deviation 
was determined. For HeLa and MEF counts, 50 nuclei from both “high serum” (10% 
FBS) and „low serum” (0.5% FBS) were scored for number of nucleoli for each day of the 
4 day time course. Counts from C2C12, HeLa and MEF cells were plotted on a graph of 
# Nuclei versus # Nucleoli. Mitotic counts were performed by randomly selecting 50 
nuclei as described above and determining the number of mitotic cells present out of the 
50 nuclei selected. Percentage of mitotic cells present was determined for C2C12, HeLa, 






Chapter 4: Examining Btf’s Role in Myogenesis 
4.1 Btf Expression Increases During Myogenesis in C2C12 Cells 
To begin to understand if Btf has a role in myogenesis, I examined Btf in 
differentiating C2C12 cells. C2C12 cells were plated, allowed to attach for 24 hours, and 
induced to differentiate by switching from growth medium (GM) to differentiation medium 
(DM). C2C12 cells were processed for immunofluorescence on Day 0 at the time on 
induction through Day 4 of the differentiation time course to immunolabel Btf as well as 
muscle specific proteins myogenin and MHC. Myogenin and MHC served as markers to 
indicate myoblasts undergoing differentiation. Cells that were positive for expression of 
myogenin exhibited increased nuclear labeling of Btf as compared to neighboring 
undifferentiated myoblasts (Figure 4.1). Increased nuclear labeling of Btf was detected in 
some cells that were not MHC positive but all cells which were positive for myogenin 
showed increased nuclear labeling of Btf (Figure 4.1 and 4.2). Increased nuclear labeling 
of Btf was also observed in myoblasts that had not yet fused into multinucleated 
myotubes (Figure 4.1 and 4.2). Immunofluorescence data taken together with 
immunoblot data collected by Alok Sharma (Figure 2.1) suggests that increased 
expression of Btf is an early event in the differentiation process. While the immunoblot 
shows globally that Btf expression increases, IF data indicates that the increase is seen 
in the myoblasts undergoing differentiation (myoblasts which stain positive for muscle-
specific proteins that serve as differentiation markers). Increased expression of Btf 
persisted through Day 4 of the
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Figure 4.1. Expression of Btf and Myogenin in differentiating C2C12 cells. After 
differentiation was induced, myoblasts began to show nuclear expression of muscle-
specific protein myogenin. Expression of myogenin appeared as early as Day 0 in 
spontaneously differentiating cells (Panels A-D, arrows, red signal indicates 
immunolabeling of myogenin with F5D anti-myogenin antibody). As early as Day 0, cells 
positive for myogenin exhibited a higher level of Btf labeling (Panels A-D, arrows, green 
signal indicates immunolabeling of Btf with WU10 antibody) as compared to neighboring 
undifferentiating cells (Panels A-D, arrowheads). Increased labeling of Btf in 
differentiating myoblasts persisted through Days 3 and 4 in nuclei of myotubes (Panels 
M-P, arrows) and Day 4 (Panels Q-T, arrows). DNA was stained with DAPI. Boxed 







Figure 4.2. Expression of Btf and MHC in differentiating C2C12 cells. After 
differentiation was induced, myoblasts began to show cytoplasmic expression of muscle-
specific protein myosin heavy chain (MHC). Expression of MHC appeared as early as 
Day 1 and marked myoblasts undergoing differentiation (Panels E-H, arrows, red signal 
indicates immunolabeling of MHC with MF20 antibody).  By Day 2, differentiating 
myoblasts (Panels I-L, arrows) exhibited higher levels of nuclear Btf as compared to 
neighboring MHC-negative myoblasts (Panels I-L, arrow heads, green signal indicates 
immunolabeling of Btf with WU10 antibody). By Day 4, MHC positive cells were more 


















differentiation time course (Figure 4.1 and Figure 4.2). All cells throughout the entire 
differentiation time course which were positive for muscle specific proteins myogenin or 
MHC exhibited increased nuclear labeling of Btf. 
4.2 Overexpression of Btf Alone does Not Induce Differentiation of C2C12 Cells 
 Because Btf expression increases early in C2C12 differentiation, we wanted to 
test whether increased expression of Btf alone might alternatively shift the timing of 
differentiation events in C2C12 cells maintained in GM. C2C12 cells were transfected 
with empty YFP plasmid DNA or YFP-Btf plasmid DNA via electroporation. C2C12 cells 
transfected with empty YFP plasmid DNA were maintained in GM for the entire time 
course as a control to assert that transfection alone did not alter the uninduced 
differentiation time course. Cells transfected with YFP-Btf were divided into two groups, 
one that was maintained in GM and another that was induced to differentiate by 
switching to DM. C2C12 cells transfected with empty YFP plasmid DNA served as a 
control to assert that any changes seen in samples transfected with YFP-Btf were not 
simply a result of the transfection process or YFP expression, but indeed a result of Btf 
overexpression. C2C12 cells that were transfected with YFP-Btf and induced to 
differentiate were used to verify that transfected cells could undergo differentiation and 
to compare the time course of transfected cells to that of a normal time course in terms 
of muscle specific protein expression and gross morphological changes. In addition to 
transfected samples, untransfected C2C12 cells were either maintained in GM or 
induced to differentiate on Day 0 of the time course by switching to DM. Untransfected 
cells were induced to differentiate in parallel and served as a normal differentiation time 
course comparison. Untransfected cells maintained in GM were used to determine the 
frequency of spontaneous differentiation of transfected cells that were not induced. By 
including all of these conditions, it was possible to compare the differentiation time 
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courses of cells overexpressing Btf (uninduced and induced) to normally differentiating  
untransfected cells (induced or uninduced), and note any changes in differentiation 
timing, cellular phenotypes, or expression of marker proteins of interest.   
 A summary of the overall experimental design for Btf overexpression can be 
found in Figure 4.3. Cells from all groups were processed for immunolabeling on Day 0, 
Day 2, and Day 4 of the time course.  Transfected C2C12 cells were processed for 
immunoflourescence labeling of muscle specific proteins myogenin and MHC. 
Transfected cells were observed for expression of myogenin and MHC as well as 
exogenous Btf. Untransfected cells were processed for immunofluorescence labeling of 
both endogenous Btf as well as muscle specific proteins myogenin and MHC. Cells that 
were transfected with empty YFP plasmid DNA and cells that were transfected with YFP-
Btf and maintained in GM showed no expression of muscle specific proteins myogenin 
or MHC until Day 4 of the time course (Figure 4.4 – Figure 4.9), indicating that 
spontaneous differentiation was infrequent in this experiment. Progression of the 
differentiation time course in cells that were not induced to differentiate appeared 
delayed in comparison to normal differentiation time courses in which myogenin 
expression occurs at Day 1 and MHC expression occurs at Day 2. Untransfected C2C12 
cells maintained in GM also showed no expression of muscle specific proteins myogenin 
or MHC until Day 4 of the time course which indicates that delayed differentiation 
observed in transfected cells maintained in GM was not a result of transfection or 
overexpression of Btf (Figure 4.6 and Figure 4.9). It is worth noting that all C2C12 cells 
that were maintained in GM failed to form multinucleated myotubes by Day 4 (Figure 4.6 
and Figure 4.9).  Cells that were transfected with YFP-Btf and were induced to 
differentiate showed expression of both myogenin and MHC at Day 2 of the time course 
(Figure 4.5 and Figure 4.8) and increased through Day 4 (Figure 4.6 and Figure 4.9)  
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Figure 4.3. Overexpression of Btf experimental design. C2C12 myoblasts were 
divided into five groups. A portion of C2C12 myoblasts were transfected with the 
parental plasmid containing only the YFP protein sequence and were maintained in 
growth medium (DMEM + 15% FBS, GM) for the entire experiment. C2C12 cells were 
also transfected with the YFP-Btf plasmid and half of the samples were induced to 
differentiate via serum deprivation and the other half was maintained in GM for the entire 
experiment. Untransfected C2C12 cells were divided into two groups and one group was 
induced to differentiate via serum deprivation for a normal time course and one group 
was maintained in GM for the entire experiment. Abbreviations for experimental 








Figure 4.4. Overexpression of Btf and  expression of myogenin at Day 0 of the 
differentiation time course. At Day 0 of the time course, none of the experimental 
conditions showed nuclear expression of muscle specific protein myogenin (red signal 
indicates immunolabeling of myogenin with F5D antibody). Both untransfected cells 
maintained in GM (Panels M-P, arrows) and untransfected cells induced to differentiate 
(Panels Q-T, arrows) contain mitotic cells indicating the cells are still in a proliferative 









Figure 4.5. Overexpression of Btf and  expression of myogenin at Day 2 of the 
differentiation time course.  At Day 2 of the differentiation time course, all cells which 
were maintained in GM still did not exhibit expression of muscle specific protein 
myogenin. Cells transfected with YFP-Btf and induced to differentiate (Panels E-H, 
arrows, red signal indicates immunolabeling of myogenin with F5D antibody) and 
untransfected cells which were induced to differentiate (Panels Q-T, arrows) contain 
cells positive for myogenin as expected of cells after 48 hours of serum deprivation 







Figure 4.6. Overexpression of Btf and  expression of myogenin at Day 4 of the 
differentiation time course.  Four days after the time course was started, all samples 
contain myoblasts positive for muscle specific protein myogenin. Cells transfected with 
empty YFP and maintained in GM were positive for myogenin at Day 4 (Panels A-D, 
arrows, green signal indicates expression of exogenous YFP) as were surrounding cells 
which were not successfully transfected (Panels A-D, arrowheads) indicating that 
transfection of YFP did not hinder the myoblast‟s ability to differentiate. Cells transfected 
with YFP-Btf and induced to differentiate (Panels E-H) showed multiple myogenin 
positive myoblasts which had fused into myotubes. Cells transfected with YFP-Btf and 
maintained in GM (Panels I-L, arrows, green signal indicates expression of YFP-Btf) 
exhibited expression levels of myogenin (red signal indicates immunolabeling of 
myogenin with F5D antibody) similar to untransfected cells maintained in GM. 
Untransfected cells that were induced to differentiate showed a normal progression of 









Figure 4.7. Overexpression of Btf and  expression of MHC at Day 0 of the 
differentiation time course. Cells transfected with empty YFP and maintained in GM 
(Panels A-D, green signal indicates expression of exogenous YFP) and cells transfected 
with YFP-Btf and maintained in GM (Panels I-L, green signal indicates expression of 
YFP-Btf) were negative for cytoplasmic expression of MHC (red signal indicates 
immunolabeling of MHC with MF20 antibody) as were untransfected cells maintained in 
GM (Panels M-P, green signal indicates immunolabeling of endogenous Btf with WU10 
antibody). Cells transfected with YFP-Btf that were induced to differentiate (Panels E-H) 
as well as cells that were not transfected and induced to differentiatecells (Panels Q-T) 
showed no expression of MHC as expected at Day 0 of the differentiation time course. 
The presence of mitotic cells in untransfected cells that were induced to differentiate 
(Panels Q-T, arrows) indicate that differentiation had not been activated. DNA was 
















Figure 4.8. Overexpression of Btf and  expression of MHC at Day 2 of the 
differentiation time course. Cells transfected with empty YFP plasmid and maintained 
in GM (Panels A-D) and cells transfected with YFP-Btf and maintained in GM (Panels I-
L) were negative for MHC expression at Day 2. Cells transfected with YFP-Btf and 
induced to differentiate (Panels E-H, green signal indicates expression of YFP-Btf) and 
untransfected cells induced to differentiate (Panels Q-T, green signal indicates 
immunolabeling of endogenous Btf with WU10 antibody) showed the greatest number of 
MHC positive cells as expected. One myoblast in the untransfected cells maintained in 
GM was positive for MHC indicating that some spontaneous differentiation was occurring 
in this experiment (Panels M-P, arrows, red signal indicates immunolabeling of MHC 

















Figure 4.9. Overexpression of Btf and  expression of MHC at Day 4 of the 
differentiation time course. By Day 4 of the time course, all experimental groups 
contained myoblasts positive for MHC expression (all Panels, red signal indicates 
immunolabeling of MHC with MF20 antibody). Cells in all groups that were induced to 
differentiate formed multi-nucleated myotubes, whereas cells in all groups maintained in 









which reflected normal timing of the differentiation time course. Untransfected C2C12 
cells that were induced to differentiate exhibited expression of myogenin and MHC at 
Day 2 and increased through Day 4 of the time course confirming the cells were 
undergoing normal differentiation (Figure 4.5 and Figure 4.6). All C2C12 cells that were 
induced to differentiate formed multinucleated myotubes by Day 4 of the time course as 
expected (Figure 4.6 and Figure 4.9). It is also worth noting that by Day 4, both induced 
and uninduced cells overexpressing YFP-Btf exhibit myotubes containing nuclei both 
positive for overexpression and negative for overexpression of YFP-Btf (Figure 4.9, 
Panels E-L). Endogenous Btf expression levels for all induced samples and all 
uninduced samples were similar as observed by immunoblot data (Figure 4.10). This 
suggests that all induced or uninduced time courses proceeded with similar timing 
regardless of overexpression of YFP or YFP-Btf and that overexpression of YFP-Btf 
produced no observable changes in endogenous Btf levels throughout the differentiation 
time course. Immunoblotting using an anti-GFP antibody which recognizes the YFP tag 
confirmed that YFP-Btf was overexpressed in the C2C12 cells. 
In addition to expression of muscle specific proteins and changes in gross 
morphology, all experimental samples were observed for presence of mitotic cells to 
determine if the cells were cycling or had exited the cell cycle. In order to differentiate, 
cells must first exit the cell cycle; therefore, observing the number of mitotic cells in a 
population served as an indicator of differentiation.  All cells that were maintained in GM 
for the duration of the experiment exhibited a higher number of mitotic cells as compared 
to cells that were induced to differentiate (Table 4.1). A lower number of mitotic cells was 
expected for cells induced to differentiate because in order to differentiate the cells must 
first exit the cell cycle. A higher proportion of mitotic cells in cells that were transfected 
with YFP-Btf maintained in GM suggests that overexpression of Btf alone was not  
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Figure 4.10. Western blot analysis to detect expression of endogenous Btf 
throughout time course testing the effect of Btf overexpression on differentiation. 
WCNE was prepared on Day 0, Day 2, and Day 4 of the differentiation time course. 
Equal total protein in each sample was loaded onto SDS-PAGE and transferred to a 
nitrocellulose membrane for immunoblotting. At Day 0 of the time course, Btf signal is 
undetectable in all samples as expected. By Day 2 of the time course Btf is detectable in 
cells which were transfected with YFP-Btf and induced to differentiate and untransfected 
cells which were induced to differentiate. A detectible signal for Btf is still absent at Day 
2 for all other samples which were maintained in GM throughout the entire time course. 










Table 4.1. Mitotic counts for all experimental conditions in Btf overexpression time 
course. One hundred cells were randomly selected for image capture and mitotic cells 
were counted for each experimental condition in the Btf overexpression time course. 
This process was repeated for cells co-labeled with myogenin and MHC. C2C12 cells 
which were transfected with the YFP plasmid and maintained in growth medium (DMEM 
+ 15% FBS, GM) showed an overall decrease in mitotic cells but still possessed more 
mitotic cells at Day 4 than any of the experimental groups in which differentiation was 
induced. C2C12 cells which were transfected with YFP-Btf and induced to differentiate 
decreased greatly in their mitotic population from Day 0 to Day 4. C2C12 cells which 
were transfected with YFP-Btf and grown in GM maintained approximately the same 
number of mitotic cells during the time course. C2C12 cells that were not transfected but 
were induced to differentiate showed an almost complete absense of mitotic cells at day 
2 and Day 4. C2C12 cells which were neither transfected nor induced to differentiate 































capable of inducing the cells to exit the cell cycle and progress along the differentiation 
pathway.  
 
4.3 Ineffective Knockdown of Btf Using siRNA 
Because Btf protein expression increases early during C2C12 differentiation, we 
wondered if Btf depletion might hinder differentiation. Undifferentiated C2C12 cells have 
a very low baseline level of Btf; therefore, determining whether Btf siRNA duplexes could 
effectively knock down Btf in undifferentiated cells would be difficult. In order to optimize 
depletion of Btf, preliminary experiments were done using HeLa and mouse embryonic 
fibroblasts (MEFs). HeLa cells were used as a control to confirm that I could produce a 
successful depletion because other lab members have optimized effective depletion of 
Btf in HeLa cells. MEFs were used because they are a mouse cell line with higher 
baseline levels of Btf in which to test oligos targeted against mouse Btf mRNA. Upon 
examination of the mouse Btf sequence, it was discovered that an oligo targeted against 
human Btf, hsi-2, matched a sequence within mouse Btf and was used along with four 
oligos targeted towards mouse Btf (msi-1-4). Preliminary experiments showed that in 
MEF cells, hsi-2 showed nearly complete depletion of Btf and msi-1 showed partial 
depletion of Btf (Figure 4.12). In addition to immunoblot data, immunoflourescence data 
confirmed that in MEF cells, hsi-2 was the most effective at knocking down Btf, and msi-
1 was also partially effective. Once the most effective oligos were chosen, we designed 
an experiment to deplete Btf and induce differentiation in C2C12 cells, as shown in the 
experimental design summary in Figure 4.11. C2C12 cells were transfected with siRNA 
buffer (mock), siRNA oligos targeted against luciferase (control), and siRNA oligos 
targeted against Btf (hsi-2) and incubated for 24 hours. Mock-treated cells served as a  
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Figure 4.11. Btf depletion via siRNA interference experimental design. C2C12 
myoblasts were transfected with either siRNA buffer (mock), siRNA oligos targeted 
against luciferase (control), or siRNA oligos targeted against Btf (hsi-2) and allowed to 
incubate for 24 hours. 24 hours after siRNA transfection (Day 0), C2C12 myoblasts were 
induced to differentitate and processed for immunolabeling of Btf and muscle specific 
proteins myogenin and MHC as well as protein extraction for immunoblotting. Cells were 









Figure 4.12 Depletion of Btf via siRNA in mouse embryonic fibroblasts (MEFs). 
MEF cells were transfected with siRNA buffer (mock), siRNA oligos targeted against 
luciferase (control), and mouse Btf (msi-1 – msi-4) and human Btf (hsi-2) and extracted 
for SDS-PAGE 48 hours after transfection. Btf was detected at ~150 kDa in mock and 
control cells. Btf. Cells treated with siRNA oligo 1 targeted against mouse Btf (msi-1) 
showed a slight depletion of Btf. Cells treated with siRNA oligo 2 targeted against human 










control to assert that vehicle alone did not hinder differentiation. siRNA oligos targeting  
luciferase were used to control for any general off-target effects of the siRNA 
transfection. C2C12 cells were then processed for immunofluorescence labeling of Btf 
and muscle specific protein MHC on Day 0, Day 2 and Day 4 of the differentiation time 
course (Figure 4.11). Muscle specific protein MHC served as a marker to indicate cells 
undergoing differentiation.  All C2C12 cells showed no expression of MHC on Day 0 of 
the differentiation time course as expected (Figure 4.13). By Day 2 of the differentiation 
time course, all experimental conditions showed myoblasts positive for MHC and an 
increased level of Btf expression (Figure 4.13). By Day 4 of the differentiation time 
course, all experimental conditions showed multinucleated myotubes (Figure 4.13). For 
all days of the differentiation time course myoblasts that were treated with siRNA oligos 
targeted against Btf did not show depletion of Btf (Figure 4.13). Different concentrations 
of siRNA reagents and post-transfection incubation periods in multiple experiments all 
yielded the same results; however, siRNA depletion of Btf was successful in MEF and 
HeLa cells. Undifferentiated C2C12 cells have very low basal levels of Btf; therefore, 
detecting depletion of Btf in undifferentiated C2C12 cells is very difficult and the cells 
were allowed to differentiate in order to determine if depletion had occured. For future 
attempts of this project I might recommend attempting siRNA transfection via 
electroporation given that ineffective depletion of Btf might have been a result of poor 
transfection efficiency, as C2C12 cells are notoriously hard to transfect, and 






Figure 4.13. Btf depletion with siRNA duplex was ineffective in C2C12. C2C12 cells 
were transfected with siRNA buffer (mock), siRNA oligos targeted against luciferase 
(control), and Btf (hsi-2) and processed 48 hours later for Day 0. At Day 0, cells treated 
with hsi-2 oligos targeted against Btf showed no apparent depletion of Btf (panels Aa, 
Ae, and Ai, green signal indicates immunolabeling of Btf with WU10 antibody and red 
signal indicates immunolabeling of MHC with MF20 antibody). At Day 2 and Day 4, Btf 
still does not appear to be depleted (Panels Ba, Be, Bi, Ca, Ce, and Ci), as the 
fluorescence labeling of Btf is similar among controls and his-2-treated cells. DNA was 






















Chapter 5: Investigating Nuclear Reorganization in C2C12 Cells 
5.1 Nuclear Speckles Reorganize During Myogenesis in C2C12 Cells.  
A preliminary experiment performed by an undergraduate honors student 
revealed reorganization of nuclear speckles during C2C12 differentiation (Theadore 
Hufford and Paula Bubulya, unpublished data). To confirm observations seen in the 
preliminary experiment and further investigate nuclear reorganization during 
differentiation of C2C12 myoblasts, I performed differentiation time course experiments 
to study organization of nuclear speckles throughout differentiation. C2C12 myoblasts 
were plated, allowed to attach for 24 hours, and induced to differentiate on Day 0 by 
switching from growth medium (GM) to differentiation medium (DM). C2C12 cells were 
processed Day 0 through Day 4 for immunofluorescence labeling of nuclear speckle 
protein Son as well as muscle specific proteins myogenin and MHC. Muscle specific 
proteins myogenin and MHC served as markers to indicate differentiating myoblasts. As 
early as Day 0, myoblasts positive for myogenin exhibited more defined, larger, and 
brighter nuclear speckles in comparison to neighboring undifferentiated myoblasts that 
showed punctuate nuclear speckle labeling (Figure 5.1).  Some MHC negative cells 
exhibited reorganized nuclear speckles (Figure 5.2). This data taken together with the 
fact that reorganized nuclear speckles were observed in myoblasts which had not yet 
fused into multinucleated myotubes suggests that nuclear speckle reorganization occurs 
is early in the differentiation time course. 
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Figure 5.1. Reorganization of nuclear speckles in differentiating myoblasts 
expressing myogenin. After induction of differentiation, myoblasts begin to exhibit 
nuclear expression of muscle specific protein myogenin. By Day 2 of the differentiation 
time course, cells positive for myogenin (Panels I-L, arrows, red signal indicates 
immunolabeling of muscle specific protein myogenin with F5D anti-myogenin antibody) 
exhibit a more defined speckle phenotype (green signal indicates immunolabling of 
nuclear speckle protein Son with polyclonal WU13 antibody) as compared to neighboring 







Figure 5.2. Reorganization of nuclear speckles in differentiating myoblasts 
expressing MHC. Approximately 48 hours after induction of differentiation, myoblasts 
begin to exhibit cytoplasmic expression of the muscle-specific protein MHC. Myoblasts 
positive for MHC (Panels I-L, arrows, red signal indicates immunlabeling of MHC with 
MF20 anti-MHC antibody) exhibit a more defined speckle phenotype (green signal 
indicates immunolabling of nuclear speckle protein Son with polyclonal WU13 antibody) 
as compared to neighboring undifferentiated myoblasts (Panels I-L, arrowheads). DNA 








5.2 Nucleoli Reorganize During Myogenesis in C2C12 Cells. 
 In addition to nuclear speckles, preliminary data showed that nucleoli in 
differentiating C2C12 cells reorganize (Theadore Hufford and Paula Bubulya, 
unpublished data). In order to confirm this data and further characterize nucleolar 
reorganization, I performed differentiation time course experiments in which I monitored 
nuclear expression and compartmentalization of rRNA processing factor fibrillarin. 
C2C12 myoblasts were plated, allowed to attach for 24 hours, and induced to 
differentiate on Day 0 by switching from GM to DM. C2C12 cells were processed on Day 
0 through Day 4 for immunofluorescence labeling of fibrillarin as well as for muscle 
specific proteins myogenin and MHC.  Myogenin and MHC served as markers to 
indicate differentiating myoblasts. Myogenin positive cells were present at Day 0 and 
Day 1; however, myogenin positive cells on Day 0 and Day 1 did not show a 
reorganization of nucleoli (Figure 5.3). By Day 2 of the differentiation time course, 
myogenin positive myoblasts showed a reorganization of nucleoli from approximately 5-
10 small punctate bodies to approximately 1-5 more prominent bodies (Figure 5.3). 
Some cells that were MHC negative exhibited reorganized nucleoli (Figure 5.4). Both 
fibrillarin and MHC are labeled in Texas Red secondary antibody because both 
antibodies were monoclonal antibodies and because the two proteins are in separate 
compartments of the cells, one secondary was used. Reorganized nucleoli were 
observed in cells which had not yet fused into multinucleated myotubes (Figure 5.4). 
Some spontaneously inducing cells also exhibited the reorganized phenotype (Theadore 
Hufford, Paula Bubulya, unpublished data). This data suggests that nucleolar 





Figure 5.3. Reorganization of nucleoli in differentiating myoblasts expressing 
myogenin. After induction of differentiation, myoblasts begin to show nuclear expression 
of muscle specific protein myogenin. By Day 2, all myoblasts positive for myogenin 
(Panels I-L, arrows, green signal indicates immunolabeling of myogenin with F5D anti-
myogenin antibody) exhibit a change in nucleolar organization (Panels I-L, arrows, red 
signal indicates immunolabeling of nucleolar component fibrillarin with polyclonal anti-
fibrillarin antibody) as compared to neighboring undifferentiated myoblasts (Panels I-L, 


















Figure 5.4.  Reorganization of nucleoli in differentiating myoblasts expressing 
MHC. Beginning on Day 1 of the differentiation time course nucleoli in differentiating 
myoblasts reorganize.  By Day 1 of the differentiation time course,  the cell indicated is 
negative for MHC expression (Panels  D-F, arrows, red signal indicates immunolabeling 
of both MHC with MF20 anti-MHC antioby and fibrillarin with monoclonal anti-fibrillarin 
antibody)  but still exhibits a reorganized nucleolar phenotype as compared to 




































5.3 Chromocenters reorganize during myogenesis in C2C12 cells 
 In addition to nuclear speckles and nucleoli, chromocenters in differentiating 
nuclei reorganized. Chromocenter reorganization and spatial clustering has been 
previously reported (Terranova et al., 2005). In undifferentiated C2C12 cells, 
chromocenters are evenly distributed throughout the nucleoplasm. However, as the 
myoblasts progress along the differentiation pathway chromocenters redistribute to the 
periphery of the nuclei. Throughout the various time course experiments performed, we 
observed in undifferentiated C2C12 cells the chromocenters were evenly distributed 
throughout the nucleoplasm. An example of this from one time experiment can be found 
in Figure 5.5, panel A. Once cells had differentiated, the chromocenters were distributed 
predominately on the periphery of the nuclei as previously reported. 
5.4 Nuclear reorganization is not an artifact of serum starvation.  
 To assert that nuclear reorganization observed in differentiating C2C12 cells was 
not an artifact of serum starvation, I performed experiments using to test the effects of 
serum starvation on both HeLa and mouse embryonic fibroblast (MEF) cells. HeLa cells 
were chosen because they are a non-mouse cell line that does not undergo the 
differentiation process; furthermore, by using this cell line I could determine if serum 
starvation causes nuclear reorganization in a non-mouse cell line not undergoing 
differentiation. If nuclear reorganization occurred in serum-starved HeLa cells it would 
suggest that the nuclear reorganization I observed in differentiating C2C12 cells was a 
result of serum starvation rather than a specific differentiation event. MEF cells were 
chosen because they are a mouse cell line that does not undergo the differentiation 
process; furthermore, nuclear reorganization occurring in serum-starved MEF cells 
would suggest that nuclear reorganization in response to serum starvation was a mouse 
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Figure 5.5. Chromocenters reorganize during myoblast differentiation in C2C12 
cells. At Day 0 of the differentiation time course chromocenters in undifferentiated cells 
are evenly distributed throughout the nucleoplasm (Panel A, white signal indicates DNA 
staining by DAPI). By Day 4 of the differentiation time course, chromocenters in 
differentiated cells have reorganized and are located predominately at the periphery of 








cell-specific phenomenon.  HeLa and MEF cells were maintained in both “high serum” 
(DMEM + 10% FBS) and “low serum” (DMEM + 0.5% FBS) for four days. On each day, 
HeLa and MEF cells maintained in both serum conditions were processed for 
immunofluorescence labeling of both nuclear speckle protein Son and nucleolar protein 
fibrillarin to simultaneously monitor nuclear speckle and nucleolar organization. Because 
HeLa and MEF cells do not undergo differentiation, no proteins were used to mark cells 
undergoing differentiation. HeLa cells maintained in high serum conditions showed no 
reorganization of nuclear speckle morphology or nucleolar morphology between Day 1 
and Day 4 (Figure 5.6). HeLa cells maintained low serum conditions exhibited no 
changes in nuclear speckle morphology or nucleolar morphology between Day 1 and 
Day 4 (Figure 5.7). MEF cells maintained in high serum conditions showed no 
reorganization of nuclear speckle or nucleolar morphology between Day 1 and Day 4 of 
the time course (Figure 5.8). MEF cells maintained in low serum conditions also showed 
no reorganization of nuclear speckle morphology or nucleolar morphology (Figure 5.9). 
Lack of nuclear speckle and nucleolar reorganization in either HeLa or MEF cells 
suggests that nuclear reorganization as observed in differentiating C2C12 cells was not 
an artifact of serum starvation. Because C2C12 cells undergoing differentiation show a 
decrease over time in the number of nucleoli per nucleus, I scored HeLa and MEF cells 
maintained in high and low serum conditions for number of nucleoli per nuclei for each 
day of the experiment. HeLa cells that were maintained in either high serum or low 
serum conditions showed no shift in the average number of nucleoli per nucleus 
between Day 1 and Day 4 indicating HeLa cell nucleoli do not reorganize as C2C12 cell 
nucleoli do during differentiation (Figure 5.10). MEF cells which were maintained in 
either high serum or low serum conditions showed no shift in average number of nucleoli 
per nucleus between Day 1 and Day 4 (5.11). Mitotic cells were scored for each 
experimental group for Day 1 through Day 4 to determine if cells maintained in either  
89 
 
Figure 5.6.  Nuclear Organization in HeLa cells maintained in normal serum 
conditions. HeLa cells maintained in DMEM + 10% FBS showed no changes in 
organization of nuclear speckles (green signal indicates immunolabeling of nuclear 
speckle protein Son with polyclonal WU13 antibody) between Day 1 (Panels A, C and D, 
arrows) and Day 4 (Panels M, O, and P, arrows). Cells maintained in the same 
conditions also do not show changes in organization of nucleoli (red signal indicates 
immunolabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin 
antibody) between Day 1 (Panels B-D, arrowheads) and Day 4 (Panels N- P, 








Figure 5.7. Serum starvation does not result in reorganization of HeLa nuclei. 
HeLa cells maintained in DMEM + 0.5% FBS (low serum conditions) showed unaltered 
organization of nuclear speckles (green signal indicates immunolabeling of nuclear 
speckle protein Son with polyclonal WU13 antibody) between Day 1 (Panels A, B, and 
D, arrows) and Day 4 (Panels M, O, and P, arrows). Cells maintained in the same 
conditions also exhibit unchanged organization of nucleoli (red signal indicates 
immunlabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin antibody) 
between Day 1 (Panels B-D, arrowheads) and Day 4 (Panels N-P, arrowheads). DNA 









Figure 5.8. Nuclear organization of mouse embryonic fibroblasts (MEFs) 
maintained in normal serum conditions. MEFs maintained in DMEM + 10% FBS 
showed unaltered organization of nuclear speckles (green signal indicates 
immunolabeling of nuclear speckle protein Son with polyclonal WU13 antibody) between 
Day 1 (Panels A, C, and D, arrows) and Day 4 (Panels M, O, and P, arrows). Cells 
maintained in the same conditions also exhibit unchanged organization of nucleoli (red 
signal indicates immunolabeling of nucleolar component fibrillarin with monoclonal anti-
fibrillarin antibody) between Day 1 (Panles B-D, arrowheads) and Day 4 (Panels N-P, 









Figure 5.9. Serum starvation does not result in reorganization of MEF nuclei. MEFs 
maintained in DMEM + 0.5% FBS showed unaltered organization of nuclear speckles 
(green signal indicates immunolabeling of nuclear speckle protein Son with polyclonal 
WU13 antibody) between Day 1 (Panels A, C, and D, arrows) and Day 4 (Panels M, O, 
and P, arrows). Cells maintained in the same conditions also exhibit unchanged 
organization of nucleoli (red signal indicates immunlabeling of nucleolar component 
fibrillarin with monoclonal anti-fibrillarin antibody) between Day 1 (Panles B-D, 









Figure 5.10. Number of Nucleoli per Nuclei Does Not Change For HeLa Cells In 
Response To Serum Starvation. HeLa cells maintained in either high serum 
concentrations (DMEM + 10% FBS, gray bars) or low serum concentrations (DMEM + 
0.5% FBS, black bars) do not exhibit any difference in average number of nucleoli per 






















Figure 5.11. Number of nucleoli per MEF nucleus does not change for MEF Cells 
after serum starvation. MEFs maintained in both high serum concentrations (DMEM + 
10% FBS, gray bars) and low serum concentrations (DMEM + 0.5% FBS, black bars) do 
not exhibit a shift in average number of nucleoli per nuclei between Day 1 (Panel A) 






















high or low serum conditions were actively cycling. Mitotic cells were scored for HeLa 
cells maintained in both high serum and low serum conditions for all four days of the 
time course. HeLa cells which were maintained in high serum conditions showed an 
overall increase in number of mitotic cells present within the population and HeLa cells 
maintained in low serum conditions shifted from 2% to 4% (Table 5.1). Mitotic cells were 
scored for MEF cells maintained in either high serum or low serum conditions for all four 
days of the time course. MEF cells maintained in high serum conditions showed an 
overall increase in number of mitotic cells present within the population and MEF cells 
maintained in low serum conditions showed a decrease of mitotic cells from 2% on Day 
1 to 0% on Day 4 (Table 5.1). A lower percentage of mitotic cells in both HeLa and MEF 
cells maintained in low serum conditions as compared to HeLa and MEF cells 
maintained in high serum conditions was expected because serum starved cells stop 
proliferating.  
5.5. Nuclear speckles and nucleoli reorganize in differenitiating myoblasts in the 
absence of serum starvation.  
 To further assert that nuclear reorganization was not an artifact of serum 
starvation in C2C12 cells, I performed a time course experiment in which C2C12 
myoblasts were plated at a higher density to allow for increased cell-to cell contact. Cell-
to cell contact among undifferentiated C2C12 cells leads to spontaneous differentiation 
in the absence of serum starvation. Additional C2C12 cells that were plated at the 
normal density and were induced to differentiate via serum starvation served as a control 
to which I could compare myoblasts undergoing self-induced differentiation. At Day 0 of 
the differentiation time course, no cells exhibited any nuclear reorganization as expected 
(Figure 5.12, panels A-D and Figure 5.13, panels A-C). By Day 4 of the time course, 
cells which were induced to differentiate via serum starvation exhibited reorganized  
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Table 5.1. Mitotic Counts for HeLa, MEF, and C2C12 Cells. Fifty cells were randomly 
selected for image capture and mitotic cells were counted for each cell line for all days of 
the serum test experiment. MEF cells maintained in high serum conditions exhibited an 
overall increase in the mitotic population from Day 1 (with 10% mitotic cells) through Day 
4 (with 14% mitotic cells). MEF cells maintained in low serum conditions show an overall 
decrease in the mitotic population beginning with 2% mitotic cells on Day 1 and ending 
with 0% mitotic cells on Day 4. HeLa cells maintained in high serum concentrations also 
showed an overall increase in the mitotic population beginning with 6% on Day 1 and 
ending with 20% on Day 4. HeLa cells maintained in low serum concentrations showed 
an overall 2% increase in mitotic populations but still had a lower percentage in 
comparison to all cell lines maintained in high serum concentrations. Upon induction to 
differentiate via serum starvation, the mitotic population of C2C12 cells decreased from 
14% on Day 0 to 0% by Day 4 and remained at 0% through Day 8 after addition of 
















Figure 5.12. Nuclear speckles reorganize in differentiating C2C12 cells in the 
absence of serum starvation. On Day 0 of the differentiation time course, both cells 
which were induced to differentiate through either cell-to cell contact (self-induced) or 
serum starvation showed no reorganization of nuclear speckles (Panels A-D and I-L, 
green signal indicates immunolabeling of nuclear speckle protein with WU13 antibody 
and red signal indicates immunolabeling of muscle specific protein myogenin with anti-
myogenin antibody). By Day 4 of the differentiation time course both self-induced and 
serum starved cells exhibited equivalent reorganization of nuclear speckles. DNA was 









Figure 5.13. Nucleoli reorganize in differentiating C2C12 cells in the absence of 
serum starvation. On Day 0 of the differentiation time course, both cells which were 
induced to differentiate through either cell-to cell contact (self-induced) or serum 
starvation showed no reorganization of nucleoli (Panels A-D and I-L, red signal indicates 
immunolabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin antibody 
and MHC with MF20 anti-MHC antibody). By Day 4 of the differentiation time course 
both self-induced and serum starved cells exhibited equivalent reorganization of nucleoli 



















nuclear speckles and nucleoli consistent with previous experiments (Figure 5.12, panels 
E-H and Figure 5.13, panels D-F). By Day 3 of the differentiation time course, the cells 
undergoing self-induced differentiation were processed as they had developed myotubes 
and were nearly 100% confluent as observed by phase contrast microscopy. At Day 3 of 
the differentiation time course, the self-induced cells showed reorganization of both 
nuclear speckles and nucleoli as observed in the serum starved cells (Figure 5.12, 
panels M-P and Figure 5.13, panels J-K). This data suggests that the nuclear 
reorganization observed in differentiating C2C12 cells is not a result of the metabolic 
changes that occur during serum starvation but rather a result of the differentiation 
process.  
5.6. The number of nucleoli per nucleus decreases in an irreversible fashion 
during differentiation. 
To determine if nuclear reorganization was reversible, I performed experiments in which 
GM was added back to C2C12 cells after Day 4 of the differentiation time course.  
C2C12 cells were scored for number of nucleoli per nuclei in both myoblasts (cells that 
were negative for muscle specific proteins myogenin or MHC) and myotubes (cells that 
were positive for muscle specific proteins myogenin or MHC) for Days 0-4 of the 
differentiation time course. Myotubes consistently had fewer nucleoli per nucleus in 
comparison to myoblasts for all four days of the differentiation time course (Figure 5.14). 
On Day 4 of one differentiation time course, GM was added back to the C2C12 cells for 
four additional days and the number of nucleoli per nucleus was again scored for both 
myoblasts and myotubes on Day 8. Myotubes again showed fewer nucleoli per nuclei 
(Figure 5.14). Failure of nucleoli to revert to the organization seen in undifferentiated 
C2C12 cells in the presence of GM suggests that nuclear reorganization is irreversible. 
109 
 
Figure 5.14. Differentiation causes irreversible nucleolar reorganization in C2C12 
myoblasts. For each day of the differentiation time course, 30 myoblast (C2C12 cells 
negative for myogenin or MHC) and 30 myotube (C2C12 cells positive for myogenin or 
MHC) nuclei were counted and number of nucleoli per nuclei was recorded. This was 
repeated for three separate experiments (1 fibrillarin + myogenin, 2 fibrillarin + MHC) 
and the number of nucleoli per nuclei averaged. Myotubes consistently show a lower 
number of nucleoli, while myoblasts exhibit a higher number of nucleoli (Panels A-E).  
For one time course experiment, at Day 4 of differentiation, growth medium was added 
back to the cells and on Day 8 the cells were fixed and counted as previously stated to 
determine if nuclear reorganization would reverse when serum-rich medium was added 
back to the cells. Nucleoli counts on Day 8 indicate that nucleolar reorganization 








5.7. Live imaging of nuclear reorganization 
Based on observations made of reorganization of nuclear speckles and nucleoli, we 
hypothesized two possible models for reorganization: nuclear domain fusion and/or  
nuclear domain recession and enlargement. In order to determine which model was 
correct, we designed experiments to image nucleolar reorganization via live cell 
microscopy. To our knowledge live imaging in C2C12 cells has not been previously 
done. As such, several parameters were optimized to increase the probability for 
successful imaging of nuclear proteins including transfection conditions and timing of 
transfection in the differentiation scheme. C2C12 cells were transfected with CFP-
fibrillarin plasmid DNA for live imaging of exogenous protein. To optimize transfection 
conditions, C2C12 cells were first transfected with 40 μg of salmon sperm carrier DNA 
and increasing amounts of plasmid DNA ranging from 2 µg-10 μg. C2C12 cells 
transfected with 4 μg of CFP-fibrillarin DNA provided the greatest level of transfection 
efficiency (Figure 5.15). C2C12 cells transfected with 40 µg of salmon sperm carrier 
DNA and 4 µg of CFP-fibrillarin DNA exhibited high transfection efficiency but high levels 
of overexpression were also observed and seemed to alter nucleolar reorganization 
(data not shown). The goal of this optimization was to express enough CFP-fibrillarin for 
image detection without altering nuclear structure. To optimize salmon sperm carrier 
DNA concentrations in order decrease overexpression, C2C12 cells were then 
transfected with 20 µg, 40 µg, 60 µg and 80 μg of salmon sperm carrier DNA. 80 µg of 
salmon sperm carrier DNA provided the greatest transfection efficiency and lowest but 
detectable levels of overexpression (Figure 5.15). C2C12 cells were transfected with 
CFP-fibrillarin and induced to differentiate 48 hours later. To limit phototoxicity in live 
imaging, it is important to establish a minimal time frame for examining reorganization.  
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Figure 5.15. Optimization for transfection of CFP-fibrillarin plasmid DNA via 
electroporation. C2C12 cells were first transfected with varying amounts of CFP-
fibrillarin plasmid DNA and 40 μg of salmon sperm carrier DNA. Following plasmid 
optimization, varying amounts of salmon sperm carrier DNA were used to transfect 
plasmid DNA. C2C12 cells transfected with 4 μg of plasmid DNA and 80 μg of salmon 
sperm carrier DNA exhibited the highest transfection efficiency and lowest levels of 







Cells were fixed at the time of differentiation induction and every 8 hours after that to 
determine a window of time during which the nucleolar phenotype changed. The 
nucleolar phenotype reorganized approximately 32-40 hours after the cells were induced 
to differentiate (Figure 5.16). Untransfected C2C12 cells were fixed alongside 
transfected samples and immunolabeled for fibrillarin to determine if exogenous and 
endogenous fibrillarin protein showed similar reorganization behavior and timing 
throughout the differentiation time course. Endogenous fibrillarin also showed that 
nuclear reorganization occurred between approximately 32-40 hours after the cells were 
induced to differentiate indicating that exogenous and endogenous protein exhibits 
similar timing throughout the differentiation time course (Figure 5.16).  Because our 
approach involved transient transfection, and because live imaging was not started until 
30 hours after differentiation was induced (as established by Figure 5.16), we wanted to 
know how soon after transfection CFP-fibrillarin was detectable in C2C12 cells to avoid 
possible loss of detectable CFP-fibrillarin expression during live imaging. C2C12 cells 
were then transfected by using the optimized conditions (Figure 5.15) and were fixed at 
12 hours, 24 hours, 36 hours and 48 hours after transfection. Expression of CFP-
fibrillarin was detectable at the earliest monitored time point of 12 hours post-transfection 
(Figure 5.17). This experiment showed that it is not necessary to wait 48 hours after 
transfection for inducing differentiation, as the optimal timing for imaging begins at 12 
hours after transfection. To image nucleolar reorganization in C2C12 cells, C2C12 cells 
were transfected with 4 μg of CFP-fibrillarin DNA and 80 μg of salmon sperm carrier 
DNA. Differentiation was induced 12 hours after transfection and live imaging was 
started 30 hours after induction and continued through 40 hours after induction. In order 
to image nuclear speckles and Cajal bodies, optimization experiments similar to those 
done with CFP-fibrillarin were performed for transfection of YFP-SF2/ASF and GFP-  
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Figure 5.16. Time track of nucleolar reorganization phenotype. C2C12 cells were 
transfected with CFP-fibrillarin and induced to differentiate 48 hours after transfection. 
Upon induction to differentiate, cells were fixed in 2% formaldehyde at 24 hours (Panel 
A, a), 32 hours (Panel B, b), and 40 hours (Figure 5.16A, panel c). At approximately 32 
hours after induction of differentiation nucleoli start to exhibit a change in nucleolar 
organization. Untransfected cells were processed alongside samples electroporated with 
CFP-fibrillarin for comparison of endogenous and exogenous fibrillarin protein 
localization patterns as well as the timing for nucleolar reorganization. Untransfected 
samples were immunolabeled for fibrillarin (green signal indicates immunolabeling of 
fibrillarin). 32 hours after induction of differentiation, some myoblasts begin to exhibit a 
reorganized phenotype (Figure 5.16B, panels g-i, arrows) while other myoblasts still 
exhibit the undifferentiated phenotype (Figure 5.16B, panels g-I, arrowheads). By 40 
hours after induction, the majority of the myoblasts exhibit the reorganized phenotype 








Figure 5.17. Determining how long after transfection expression of CFP-fibrillarin 
persists. C2C12 cells were transfected with CFP-fibrillarin and fixed at 12 hours (A), 24 
hours (B), 36 hours (C), and 48 hours after transfection. Expression of CFP-fibrillarin 
was detectible at 12 hours after transfection in some myoblasts (Panel A) and increased 
through 48 hours (Panel D). DAPI was not used due to bleed through between the CFP 








coilin in C2C12 cells. Optimization of YFP-SF2/ASF revealed that transfection of 4μg of 
YFP-SF2/ASF plasmid DNA and 60 μg of salmon sperm carrier DNA yielded the highest 
transfection efficiency with the lowest levels of exogenous expression Figure 5.18). 
Significant overexpression of exogenous fusion proteins was avoided to ensure that any 
observed changes in nuclear organization would not be attributed to elevated levels of 
fusion proteins. Optimization experiments with GFP-coilin showed that GFP-coilin does 





Figure 5.18. Optimization of transfection of YFP-SF2/ASF plasmid DNA via 
electroporation. C2C12 cells were transfected with 60 μg of Salmon Sperm carrier DNA 
and 4 μg (Panel Aa-Ac), 6 μg (Panels Ad-Af), and 8 μg (Panels Ah-Ai) YFP-SF2/ASF 
DNA. C2C12 cells were also transfected with 80 μg of Salmon Sperm carrier DNA and 
C2C12 cells transfected with 60 μg of salmon sperm carrier DNA and 4 μg (Panel Ba-


























Figure 5.19. GFP-coilin does not localize correctly in C2C12 cells. C2C12 cells were 
transfected with 60μg of salmon sperm carrier DNA and varrying amounts of GFP-Coilin 
plasmid DNA (A) as well as 80μg of salmon sperm carrier DNA and varying amounts of 
GFP-Colin plasmid DNA (B). In all cells transfected, GFP-coilin failed to localize to Cajal 











Chapter Six: Discussion 
 Emery-Dreifuss is one of three major forms of muscular dystrophy and is an X-
linked disorder that arises from defects in nuclear-associated proteins, most notably 
emerin (Fairley et al., 1999). A subset of EMDM patients exhibit mutation in emerin, and 
they demonstrate normal expression levels and subcellular localization of emerin at the 
inner nuclear membrane. This is in contrast to the majority of EMDM patients whom 
produce no detectable emerin as observed by immunoblotting and 
immunohistochemistry (Haraguchi et al., 2004). This set of mutations includes a serine 
to phenylalanine substitution at residue 54 (S54F), a proline to histidine substitution at 
residue 183, a deletion of residues 95-99 (Δ95-99), and a proline to threonine 
substitution at residue 183 (Haraguchi et al., 2004). Two of these mutations, S54F and 
Δ95-99 have been mapped to  regions of emerin that associate with Btf fragments by 
yeast-two-hybrid assay (Haraguchi et al., 2004). Given Btf‟s possible role in EDMD, I set 
out to investigate a possible role for Btf in muscle cells. Initial experiments revealed that 
Btf is upregulated during muscle cell differentiation; furthermore, surprising changes in 
nuclear organization during differentiation were discovered (Theadore Hufford and Paula 
Bubulya, unpublished data).  
 In order to elucidate a possible role for Btf in muscle cells, I performed 
differentiation time courses throughout which I immunolabeled Btf and muscle specific 
proteins myogenin and MHC. Myogenin expression in the nucleus increases early in the 
differentiation time course with expression increasing at approximately Day 1 of the time 
course. MHC expression in the cytoplasm increases later in the differentiation time 
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course at approximately Day 3; however, MHC expression has been observed at Day 2 
in a limited number of myoblasts. Using these two muscle markers allowed us to classify 
increased expression of Btf as an early or late event the differentiation time course. 
Throughout the differentiation time course all cells which were positive for either 
myogenin or MHC showed increased expression levels of Btf. Increased expression 
levels of Btf was determined to be an early event in the differentiation time course. Upon 
first observation, it appeared that all myogenin positive myoblasts were also positive for 
increased expression levels of Btf. However, many MHC positive myoblasts were not 
positive for increased levels of expression. To quantify this, 100 myogenin positive cells 
were scored for the presence or absence of increased expression levels of Btf and all 
100 myogenin positive myoblasts were also positive for increased expression levels of 
Btf. In addition, I could not locate any myogenin negative myoblasts which were positive 
for increased expression levels of Btf. No parallel counts were done for myoblasts 
immunolabeled for MHC and Btf because it can be assumed based on the differentiation 
time line that if MHC is present, myogenin must also be present as it precedes MHC in 
the differentiation time course and increased expression of Btf is always present when 
myogenin is present. However, numerous MHC negative cells were observed to be 
positive for increased expression levels of Btf. This data together indicates that 
increased expression of Btf occurs either simultaneously with increased myogenin 
expression or very soon after increased myogenin expression and before increased 
MHC expression. Given that increased expression levels of Btf is an early event in the 
differentiation time course, we wanted to determine if overexpression of Btf could alone 
lead to the increased expression of muscle markers myogenin and MHC and drive the 
differentiation pathway.   
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To determine if overexpression of Btf was capable of inducing differentiation in 
the absence of serum deprivation, Btf was overexpressed in C2C12 cells and 
maintained in GM. C2C12 cells were also transfected with YFP plasmid DNA to rule out 
transfection alone as the cause of any alterations observed in C2C12 cells transfected 
with YFP-Btf plasmid DNA.  C2C12 cells were also transfected with YFP-Btf and induced 
to differentiate via serum deprivation to confirm that cells overexpressing Btf were 
capable of differentiating and that overexpression of Btf did not speed up or slow down 
the differentiation time course. Untransfected C2C12 cells were maintained in growth 
medium to ensure that any observations made in transfected samples which were not 
induced to differentiate would not occur normally in C2C12 cells without serum 
starvation. Another group of untransfected C2C12 cells were induced to diffentiate to 
serve as a direct comparison to a normal differentiation time course.  
According to immunfluorescence data, cells which were transfected with YFP 
plasmid DNA, YFP-Btf DNA and not induced to differentiate, and untransfected cells 
which were not induced to differentiate showed very slight differentiation by Day 4 
indicating that overexpression of Btf alone was not enough to induce differentiation. 
Furthermore, by Day 4 of the time course we observe transfected myoblasts 
incorporated into myotubes with other non-transfected myoblasts indicating that they are 
still competent to differentiate and are indistinguishable to other non-transfected 
myobasts (Figure 4.19).  Given that both transfected and untransfected samples which 
were not induced to differentiate showed similar levels of differentiation indicates that 
transfection did not hinder the cells‟ ability to differentiate. C2C12 cells which were 
transfected with YFP-Btf and induced to differentiate and untransfected cells which were 
induced to differentiate exhibited similar levels of differentiation at Day 0, Day 2, and Day 
4 indicating that overexpression of Btf neither slowed down or expedited differentiation. 
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In addition to immunolabeling for muscle specific proteins, future repetitions of this 
experiment could be repeated including duplicates of each sample that are 
immunolabeled for both nuclear speckle protein Son and nucleolar component fibrillarin 
to observe for nuclear reorganization as another dimension of differentiation.  
Immunoblot data in this experiment seems to correlate with the 
immunofluorescence data in that cells which were transfected with YFP-Btf and not 
induced to differentiate show equivalent Btf expression with untransfected and 
uninduced samples. This data indicates that in the absence of serum starvation cells 
overexpressing Btf progress along the differentiation pathway at the same rate as the 
uninduced differentiation time course. In order to confirm YFP-Btf was truly 
overexpressed, the blot was re-probed to detect the YFP signal. Repeated attempts 
failed to show an YFP signal on the blot; however, using immunofluorescence data, 100 
myoblasts that were transfected with YFP-Btf and not induced to differentiate and 100 
myoblasts that were transfected with YFP-Btf and induced to differentiate were scored 
on Day 0 of the differentiation time course. Day 0 was chosen because the transfection 
was transient so Day 0 was the time point at which successfully transfected cells would 
be present at the highest levels. In cells that were transfected with YFP-Btf and not 
induced to differentiate 42/100 myoblasts were positive for YFP-Btf. In cells that were 
transfected with YFP-Btf and induced to differentiate 39/100 myoblasts were positive for 
YFP-Btf. Once a myoblast has started the differentiation program, that myoblast will 
signal any other myoblast it comes into cell-to cell contact with to differentiate as well. 
Therefore, given the rate of transfection and that the cells were approximately 50-60% 
confluent at Day 0 it is reasonable to conclude that enough transfected cells were 
present and were in close enough proximity to untransfected cells to cause a observable 
change in the differentiation time course if overexpression of Btf did indeed alter the 
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differentiation time course. In addition to probing for endogenous Btf, this immunoblot 
could be probed for muscle specific proteins myogenin and MHC to further confirm or 
refute that the differentiation time course is not expedited or hindered by overexpression 
of YFP-Btf. When examining the immunoblot data there is one discrepancy between the 
immunoblot and immunofluorescence data. At Day 0 in the immunofluorescence data 
there appears to be a slight signal for endogenous Btf; however, in the immunoblot there 
is no baseline signal for Btf at Day 0 in any of the samples. This discrepancy could have 
resulted from the fact that the WU10 anti-Btf antibody is more sensitive or effective at 
detecting Btf protein in the immunofluorescence method versus the immunoblot method. 
Many antibodies are known to work more effectively or exclusively for one method or the 
other. Another irregularity found within the blot is the absence of a second Btf band. Give 
that the YFP-tag adds molecular weight to the protein another band indicating 
exogenous Btf should be found slightly above the endogenous Btf band; however, no 
band was present. One final unexpected piece of data found within the immunoblot 
corresponds to the Btf signal for cells which were not transfected and not induced to 
differentiate at Day 4. This sample shows a much more intense signal for endogenous 
Btf. If this signal truly correlates to a higher expression level of Btf in these cells, it would 
be worthwhile in future experiments to see if myoblasts which were not induced to 
differentiate consistently show higher expression levels of Btf in comparison to other 
myoblasts that were induced to differentiate by Day 4 of the differentiation time course. If 
this were the case, it would be valuble to investigate a possible role for Btf in promoting 
cycling in cells. In order to test this theory, one could overexpress YFP-Btf in a number 
of cells lines that do not differentiate and compare mitotic indices of the cells 
overexpressing YFP-Btf to each cell line‟s baseline mitotic index.  
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Together, the immunofluorescence and immunobot data indicates that increased 
expression levels of Btf do not alter the differentiation time course. It must be considered 
that the YFP- tag on the Btf protein might interfere with the function of Btf in this 
instance. However, immunoprecipitation experiments performed by other students in our 
lab showed that YFP-Btf formed complexes with nuclear membrane protein emerin just 
as endogenous Btf does (Lauren Ford, Kelly Conti and Paula Bubulya, unpublished 
data). Furthermore, this experiment showed that myoblasts overexpressing Btf were still 
competent to differentiate and form myotubes along with myoblasts expressing 
endogenous Btf. Together this data indicates to us that the function of Btf is most likely 
not hindered by the YFP tag. However, given that no information regarding Btf‟s tertiary 
structure is available, it must remain a possibility that the placement of the YFP tag may 
interfere with some unknown functions of Btf in vivo.  
Protein depletion is one of the most basic molecular approaches to elucidating a 
protein‟s function. In order to determine a possible role or function for Btf in myogenesis, 
we designed experiments to deplete Btf mRNA (and thereby Btf protein) using a 
lipofectamine-mediated transfection. In order to ensure that these experiments were 
effective, I first performed siRNA depletion of Btf in HeLa cells using a previously 
established protocol from our lab. These experiments were successful and showed that 
in my hands I could produce a successful depletion of Btf. To begin optimizing the 
protocol for mouse cells, I first performed experiments in which I depleted Btf in mouse 
embryonic fibroblasts (MEFs). MEFs were used because undifferentiated C2C12 cells 
have nearly undetectable baseline levels of Btf; however, baseline levels of Btf in MEFs 
are much higher. This eliminated the complication of optimizing depletion of Btf in 
C2C12 cells while attempting to differentiate which would be nearly impossible. While 
optimizing the protocol in MEFs, four different siRNA oligos targeted against mouse Btf 
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were tested as well as one siRNA oligo targeted against human Btf which was identical 
in sequence to a portion of the mouse Btf sequence. These experiments revealed that 
the siRNA oligo targeted against human Btf (hsi-2) produced complete knockdown of Btf 
in MEFs as detected by immunoblot. After numerous attempts using the optimized 
conditions, siRNA transfection failed to produce effective knockdown of Btf in C2C12 
cells as observed by both immunofluorescence and immunoblot. The inability to produce 
an effective knockdown of Btf in C2C12 cells is not surprising because C2C12 cells are 
notoriously hard to transfect and special products are often needed to increase the 
efficiency of lipofectamine-mediated transfection. In the future, it might be more useful to 
use electroporation as the method of transfection because a successful electroporation 
protocol for C2C12 cells has been established. Depletion of Btf in HeLa and MEF cells 
takes approximately 72 hours; therefore, even if successful depletion of Btf was 
achieved in C2C12 cells, by the time Btf was depleted the cells would most likely 
become too confluent and spontaneous differentiation could occur. If the experimental 
conditions can‟t be controlled, such as induction of differentiation, then the experiment 
will not produce reliable results and that data would be rendered useless. In addition to 
immunoblot data, incorporating RT-PCR data to examine RNA levels of Btf following 
siRNA transfection would be helpful. If the RT-PCR results revealed that Btf was 
depleted at the RNA level it might be interesting to investigate the turnover rate and half-
life of the Btf protein through fluorescence recovery after photobleaching (FRAP) and 
cyclohexamide studies. Although the siRNA transfection did not effectively deplete Btf, 
this was an important experiment to attempt given that expression levels of Btf increase 
early in muscle cell differentiation and therefore may have a vital function in myogenesis.  
If depletion of Btf had been successful and sequential experiments showed that in the 
absence of Btf C2C12 cells failed to differentiate in response to serum starvation this 
would have indicated that Btf does play an essential role in myogenesis. If previously 
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proposed experiments in which YFP-Btf was overexpressed in various cell lines revealed 
Btf positively regulated cell proliferation, it would be interesting to see if successful 
depletion of Btf could result in C2C12 differentiation in the absence of serum starvation.  
 In order to study nuclear reorganization in differentiating C2C12 myoblasts, I 
focused on tracking nuclear speckles and nucleoli throughout differentiation. Throughout 
differentiation of C2C12 myoblasts, nuclear speckles reorganized from a diffuse pattern 
to a more defined, large, and bright pattern as observed by immunofluorescence 
microscopy (Figures 4.1 and 4.2). Myogenin is upregulated earlier in the differentiation 
time course, by Day 1 (Figure 2.1) and MHC is upregulated later at Day 2 of the 
differentiation time course. Using these two muscle specific proteins to label 
differentiating myoblasts, I was able to conclude that nuclear speckle reorganization 
occurs at least as early as myogenin upregulation (Day 1) and before MHC upregulation 
(Day 2) as all myogenin positive cells exhibited reorganized nuclear speckles as well as 
some MHC negative myoblasts (Figure 4.1 and Figure 4.2). Nuclear speckle 
reorganization also occurs independently of multinucleation (Figure 4.1 and Figure 4.2). 
Nuclear speckle reorganization is slightly less distinct than nucleolar reorganization. 
Furthermore, given that the brightness of the immunofluorescence signal is one 
characteristic used to identify reorganized nuclei, it is important to find some way of 
standardizing and quantifying this reorganization. One way to do this would be to 
measure multiple nuclear speckles in both myoblasts and myobubes and set a threshold 
measurement to distinguish the reorganized nuclear speckle pattern from the nuclear 
speckle pattern in undifferentiated nuclei.  
 Nucleoli also underwent reorganization during differentiation of C2C12 
myoblasts. It was observed that myoblasts consistently possessed approximately 5-10 
nucleoli per nuclei and myotubes possessed approximately 1-5 nucleoli per nuclei, a 
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trend that when graphed created a characteristic shift in peaks between myoblasts and 
myotubes (Figure 4.11).  GM was added back to differentiated myoblasts at Day 4 and 
nucleoli counts were repeated at Day 8 and the shift in peaks was still present indicating 
that nucleolar reorganization is not irreversible. Nucleoli reorganized between 
approximately Day 1 and Day 2 (Figure 4.3 and Figure 4.4). At Day 0, spontaneously 
differentiating myoblasts which were positive for myogenin did not exhibit the 
reorganized nucleolar phenotype (Figure 4.3, Panels A-D) but all MHC positive 
myoblasts did (Figure 4.4) indicating that nucleolar phenotype may take place soon after 
myogenin upregulation but before MHC expression. To further examine nucleolar 
reorganization, I optimized conditions for live cell imaging of differentiating C2C12 cells. 
To our knowledge live cell imaging of C2C12 cells had never been published. In order to 
film nucleolar reorganization in differentiating C2C12 cells I had to first optimize 
transfection of CFP-fibrillarin. Once I had optimized transfection of CFP-fibrillarin, I then 
performed time course experiments in which I fixed transfected cells every eight hours in 
order to determine a optimal window of time during which nucleoli reorganize. 
Untransfected cells were fixed congruently with the transfected cells and labeled for 
endogenouse fibrillarin to confirm that endogenous and exogenous fibrillarin localized 
and reorganized in the same manner. Finally, because the transfection of CFP-fibrillarin 
was transient, I performed experiment to determine the earliest point at which the CFP-
fibrillarin was detectable so that I could begin the differentiation time course as soon as 
possible. After numerous attempts, I obtained a video which suggests that nucleolar 
fusion is the method of reorganization for nucleoli. Many more data sets must be 
obtained and quantified before we can confidently conclude that nucleolar fusion is the 
method of nucleolar reorganization.  
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 In order to assert that the observed nuclear reorganization was not an artifact of 
experimental manipulation performed to induce differentiation, specifically, serum 
starvation, I performed a serum starvation test on additional cells lines which do not 
undergo differentiation. MEF cells were chosen because they do not undergo 
differentiation and MEFs are a mouse cell line. HeLa cells were also used for the serum 
starvation test. By using MEF and HeLa cells, I was able to rule out that nuclear 
reorganization was simply an artifact of serum starvation and that the nuclear 
reorganization observed was a mouse-specific phenomenon.  For each day to the serum 
starvation test, MEF and HeLa cells maintained in high serum conditions (DMEM + 10% 
FBS) as well as low serum conditions (DMEM + 0.05% FBS) were fixed in formaldehyde 
and immunolabled for nuclear speckle protein Son and nucleolar protein fibrillarin 
(Figures 4.5, 4.6, 4.8, and 4.9). The number of nucleoli per nuclei of both HeLa (Figure 
4.7) and MEF (Figure 4.10) cells were scored to see if the number of nucleoli per nuclei 
would change as observed in C2C12 nucleoli counts of myoblasts and myotubes (Figure 
4.11). A change in the average number of nucleoli per nuclei between high serum and 
low serum was not observed for either HeLa or MEF cells which again indicated that 
nuclear reorganization is neither mouse specific or a result of serum starvation. On Day 
2, MEF cells exhibited a slight change in the average number of nucleoli per nuclei, MEF 
cells maintained in low showed an average of three nucleoli per nuclei and MEF cells 
maintained in high concentrations showed an average of four nucleoli per nuclei (Figure 
4.10). However, the shift in average number of nucleoli per nuclei was very slight in 
comparison to the shift of peaks which were observed in C212 counts in which 
myoblasts (cells negative for muscle specific proteins myogenin and MHC) showed an 
average of six to nine nucleoli per nuclei and myotubes (cells positive for muscle specific 
proteins myogenin or MHC) showed an average of three nucleoli per nuclei. Mitotic cells 
were also scored for HeLa, MEF, and C2C12 cells to assert that the HeLa and MEF cells 
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were reacting to serum starvation as expected. Both MEF cells maintained in low serum 
conditions and C2C12 cells showed a significant decrease in mtitoc cells between Day 1 
and Day 4 of the time course, which was expected. HeLa cells maintained in low serum 
conditions actually showed an overall 2% increase in mitotic cells and ended with a 4% 
mitotic population on Day 4; however, in comparison to all cells maintained in high 
serum conditions the HeLa cells maintained in low serum conditions still had a much 
lower proportion of mitotic cells within the population (Table 4.1).  
 In addition to experiments using HeLa and MEF cell lines, an experiment was 
done with C2C12 cells in which differentiation was induced without serum starvation. In 
this experiment the C2C12 cells were plated at a higher density than normal to allow for 
increased cell-to cell contact resulting in spontaneous differentiation. Throughout this 
differentiation time course the growth medium (GM) was replenished every 48 hours to 
ensure the absence of serum starvation. The cells that were induced to differentiate 
through cell-to cell contact in the absence of serum starvation exhibited reorganization of 
both nuclear speckles and nucleoli identical to the nuclear reorganization observed in a 
normal time course. This data, together with the HeLa and MEF serum starvation 
experiments, suggests that the nuclear reorganization observed in differentiating C2C12 
cells is not mouse specific nor a result of serum starvation but a result of the 
differentiation process. This experiment could have also been done by plating the cells 
at the normal density and inducing differentiation chemically with paraquat, which has 
been previously shown to induce differentiation in C2C12 cells (Okabe et al., 2009). 
Overexpressing the inhibitor of differentiation (Id) protein in order to prevent 
differentiation in the presence of serum starvation in C2C12 cells would also assert 
whether or not the observed nuclear reorganization is a result of serum starvation. 
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Finally, depleting MyoD and serum starving C2C12 cells could also be used to assert or 
deny that nuclear reorganization is a result of nuclear reoganziation.  
 Given that nuclear speckles posses numerous pre-mRNA processing factors and 
gene expression is greatly altered in order in order to induce differentiation, I believe that 
reorganization of nuclear speckles is a result of shifts in gene expression which occur 
during differentiation and nucleoli appear larger and more prominent in differentiated 
cells. The number of nucleoli present in C2C12 nuclei is reduced during differentiation. 
Studies have shown that proliferating cells have a much higher number of nucleoli in 
comparison to primary cells which are not in a proliferative state (Terekov, et al., 1984). 
In order to differentiate, myoblasts must first stop dividing and exit the cell cycle; 
therefore, the decrease in number of nucleoli per nuclei observed in differentiating 
myoblasts may be a result of the shift away from a proliferative state which occurs during 
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